| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | chromatin binding | HHEX SFPQ GPER1 YBX1 POLG PARP2 ACTN4 AR MEF2C PARP1 PBRM1 NFATC2 EGR1 SAMD11 ASXL3 ANKRD17 SMARCE1 KDM1A | 1.50e-05 | 739 | 153 | 18 | GO:0003682 |
| GeneOntologyMolecularFunction | LIM domain binding | 3.58e-05 | 9 | 153 | 3 | GO:0030274 | |
| GeneOntologyMolecularFunction | NAD+-protein-serine ADP-ribosyltransferase activity | 5.83e-05 | 2 | 153 | 2 | GO:0140805 | |
| GeneOntologyMolecularFunction | NAD DNA ADP-ribosyltransferase activity | 1.74e-04 | 3 | 153 | 2 | GO:0140294 | |
| GeneOntologyMolecularFunction | neurexin family protein binding | 2.30e-04 | 16 | 153 | 3 | GO:0042043 | |
| GeneOntologyMolecularFunction | androsterone dehydrogenase (B-specific) activity | 3.46e-04 | 4 | 153 | 2 | GO:0047042 | |
| GeneOntologyMolecularFunction | ketoreductase activity | 3.46e-04 | 4 | 153 | 2 | GO:0045703 | |
| GeneOntologyMolecularFunction | indanol dehydrogenase activity | 3.46e-04 | 4 | 153 | 2 | GO:0047718 | |
| GeneOntologyMolecularFunction | NAD+-protein-glutamate ADP-ribosyltransferase activity | 3.46e-04 | 4 | 153 | 2 | GO:0140807 | |
| GeneOntologyMolecularFunction | chlordecone reductase activity | 3.46e-04 | 4 | 153 | 2 | GO:0047743 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | FOXJ2 HHEX CDX4 HIVEP2 AR MEF2C CASZ1 MEIS2 FOXL2 NFATC2 EGR1 ZNF341 FOXF2 | 4.27e-04 | 566 | 153 | 13 | GO:0001216 |
| GeneOntologyMolecularFunction | trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity | 5.75e-04 | 5 | 153 | 2 | GO:0047115 | |
| GeneOntologyMolecularFunction | 15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity | 5.75e-04 | 5 | 153 | 2 | GO:0047020 | |
| GeneOntologyMolecularFunction | 17-beta-ketosteroid reductase (NADPH) activity | 5.75e-04 | 5 | 153 | 2 | GO:0072555 | |
| GeneOntologyMolecularFunction | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity | 5.75e-04 | 5 | 153 | 2 | GO:0047006 | |
| GeneOntologyMolecularFunction | lithocholic acid binding | 5.75e-04 | 5 | 153 | 2 | GO:1902121 | |
| GeneOntologyMolecularFunction | ketosteroid monooxygenase activity | 5.75e-04 | 5 | 153 | 2 | GO:0047086 | |
| GeneOntologyMolecularFunction | NAD+-protein-aspartate ADP-ribosyltransferase activity | 5.75e-04 | 5 | 153 | 2 | GO:0140806 | |
| GeneOntologyMolecularFunction | Delta4-3-oxosteroid 5beta-reductase activity | 5.75e-04 | 5 | 153 | 2 | GO:0047787 | |
| GeneOntologyMolecularFunction | HMG box domain binding | 6.98e-04 | 23 | 153 | 3 | GO:0071837 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | DAB2IP FLNB NLGN4Y ACTN4 ACTN1 ACTN2 PICALM ADD1 NLGN3 NLGN4X PPME1 NUMB CDH7 | 7.24e-04 | 599 | 153 | 13 | GO:0050839 |
| GeneOntologyMolecularFunction | geranylgeranyl reductase activity | 8.57e-04 | 6 | 153 | 2 | GO:0045550 | |
| GeneOntologyMolecularFunction | protein domain specific binding | DAB2IP WHRN HHEX RIPK2 U2AF2 ACTN1 ACTN2 BCAR1 PICALM AR MEF2C SYNGAP1 HOXA3 SAMD11 CLTC KAT14 | 1.13e-03 | 875 | 153 | 16 | GO:0019904 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | FOXJ2 SOX5 HHEX KLF8 ZNF777 CDX4 HIVEP2 SCRT1 GPER1 ZNF619 AR MEF2C CASZ1 MEIS2 HOXA3 FOXL2 NFATC2 EGR1 ZNF341 SAMD11 FOXF2 HOMEZ | 1.14e-03 | 1412 | 153 | 22 | GO:0000981 |
| GeneOntologyMolecularFunction | 17-beta-hydroxysteroid dehydrogenase (NADP+) activity | 1.19e-03 | 7 | 153 | 2 | GO:0072582 | |
| GeneOntologyMolecularFunction | nuclear receptor coactivator activity | 1.23e-03 | 61 | 153 | 4 | GO:0030374 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | FOXJ2 HHEX CDX4 HIVEP2 AR MEF2C CASZ1 MEIS2 FOXL2 NFATC2 EGR1 FOXF2 | 1.29e-03 | 560 | 153 | 12 | GO:0001228 |
| GeneOntologyMolecularFunction | Toll-like receptor binding | 1.39e-03 | 29 | 153 | 3 | GO:0035325 | |
| GeneOntologyMolecularFunction | 5alpha-androstane-3beta,17beta-diol dehydrogenase activity | 1.58e-03 | 8 | 153 | 2 | GO:0047024 | |
| GeneOntologyMolecularFunction | androsterone dehydrogenase activity | 1.58e-03 | 8 | 153 | 2 | GO:0047023 | |
| GeneOntologyMolecularFunction | enone reductase activity | 1.58e-03 | 8 | 153 | 2 | GO:0035671 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | FOXJ2 SOX5 HHEX KLF8 ZNF777 CDX4 HIVEP2 SCRT1 ACTN4 ZNF619 AR MEF2C CASZ1 MEIS2 HOXA3 FOXL2 NFATC2 EGR1 ZNF341 TET3 KDM1A FOXF2 | 1.73e-03 | 1459 | 153 | 22 | GO:0000977 |
| GeneOntologyMolecularFunction | androstan-3-alpha,17-beta-diol dehydrogenase activity | 2.03e-03 | 9 | 153 | 2 | GO:0047044 | |
| GeneOntologyMolecularFunction | NADP+ binding | 2.03e-03 | 9 | 153 | 2 | GO:0070401 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor binding | 2.22e-03 | 34 | 153 | 3 | GO:0050750 | |
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 2.41e-03 | 35 | 153 | 3 | GO:0015020 | |
| GeneOntologyMolecularFunction | testosterone 17-beta-dehydrogenase (NADP+) activity | 2.52e-03 | 10 | 153 | 2 | GO:0047045 | |
| GeneOntologyMolecularFunction | bile acid binding | 2.52e-03 | 10 | 153 | 2 | GO:0032052 | |
| GeneOntologyMolecularFunction | ubiquitin conjugating enzyme binding | 2.62e-03 | 36 | 153 | 3 | GO:0031624 | |
| GeneOntologyMolecularFunction | medium-chain fatty acid-CoA ligase activity | 3.07e-03 | 11 | 153 | 2 | GO:0031956 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 3.23e-03 | 187 | 153 | 6 | GO:0016922 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor binding | 3.29e-03 | 39 | 153 | 3 | GO:0070325 | |
| GeneOntologyBiologicalProcess | vesicle cargo loading | 2.64e-07 | 36 | 155 | 6 | GO:0035459 | |
| GeneOntologyBiologicalProcess | postsynaptic membrane assembly | 9.72e-07 | 11 | 155 | 4 | GO:0097104 | |
| GeneOntologyBiologicalProcess | male courtship behavior | 1.66e-06 | 4 | 155 | 3 | GO:0008049 | |
| GeneOntologyBiologicalProcess | intracellular receptor signaling pathway | CYLD FAM120B GPER1 RIPK2 ACTN4 AKR1C1 AKR1C2 AR PARP1 PTPRS ANKRD17 UNC93B1 PUM1 KDM1A | 3.25e-06 | 416 | 155 | 14 | GO:0030522 |
| GeneOntologyBiologicalProcess | courtship behavior | 1.42e-05 | 7 | 155 | 3 | GO:0007619 | |
| GeneOntologyBiologicalProcess | positive regulation of synaptic vesicle clustering | 2.27e-05 | 8 | 155 | 3 | GO:2000809 | |
| GeneOntologyBiologicalProcess | muscle structure development | BCL9L FLNB FLNC CHODL GPER1 YBX1 PARP2 ACTN4 ACTN1 ACTN2 MEF2C MYORG PBRM1 FOXL2 NFATC2 EGR1 ANKRD17 SMARCE1 KDM1A | 2.47e-05 | 858 | 155 | 19 | GO:0061061 |
| GeneOntologyBiologicalProcess | muscle cell development | 2.73e-05 | 259 | 155 | 10 | GO:0055001 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | DAB2IP FOXJ2 BCL9L HHEX SFPQ CDX4 HIVEP2 GPER1 YBX1 RIPK2 ACTN4 SSBP3 AR MEF2C CASZ1 MEIS2 PARP1 FOXL2 NFATC2 EGR1 ASXL3 SSBP4 TET3 KDM1A FOXF2 | 4.07e-05 | 1390 | 155 | 25 | GO:0045944 |
| GeneOntologyBiologicalProcess | dendrite development | DAB2IP CSMD3 PICALM MEF2C SYNGAP1 NLGN3 PBRM1 PTPRS PALM NUMB ALK | 4.76e-05 | 335 | 155 | 11 | GO:0016358 |
| GeneOntologyBiologicalProcess | presynaptic membrane assembly | 4.81e-05 | 10 | 155 | 3 | GO:0097105 | |
| GeneOntologyBiologicalProcess | cellular response to calcium ion | 5.33e-05 | 88 | 155 | 6 | GO:0071277 | |
| GeneOntologyBiologicalProcess | somatic sex determination | 5.61e-05 | 2 | 155 | 2 | GO:0018993 | |
| GeneOntologyBiologicalProcess | postsynapse assembly | 7.27e-05 | 93 | 155 | 6 | GO:0099068 | |
| GeneOntologyBiologicalProcess | synaptic vesicle endocytosis | 8.68e-05 | 96 | 155 | 6 | GO:0048488 | |
| GeneOntologyBiologicalProcess | regulation of synaptic vesicle clustering | 8.71e-05 | 12 | 155 | 3 | GO:2000807 | |
| GeneOntologyBiologicalProcess | presynaptic membrane organization | 1.13e-04 | 13 | 155 | 3 | GO:0097090 | |
| GeneOntologyBiologicalProcess | presynaptic endocytosis | 1.22e-04 | 102 | 155 | 6 | GO:0140238 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | DAB2IP SOX5 HHEX KLF8 ZNF777 SFPQ CDX4 SCRT1 YBX1 AR MEF2C SF1 MEIS2 PARP1 FOXL2 ZNF608 NFATC2 EGR1 SAMD11 RECQL5 SMARCE1 KAT14 KDM1A FOXF2 | 1.23e-04 | 1399 | 155 | 24 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | DAB2IP SOX5 HHEX KLF8 ZNF777 SFPQ CDX4 SCRT1 YBX1 AR MEF2C SF1 MEIS2 PARP1 FOXL2 ZNF608 NFATC2 EGR1 SAMD11 RECQL5 SMARCE1 KAT14 KDM1A FOXF2 | 1.43e-04 | 1413 | 155 | 24 | GO:1902679 |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated signaling pathway | 1.48e-04 | 202 | 155 | 8 | GO:0141193 | |
| GeneOntologyBiologicalProcess | benzene-containing compound metabolic process | 1.67e-04 | 37 | 155 | 4 | GO:0042537 | |
| GeneOntologyBiologicalProcess | territorial aggressive behavior | 1.67e-04 | 3 | 155 | 2 | GO:0002124 | |
| GeneOntologyBiologicalProcess | regulation of base-excision repair | 1.67e-04 | 3 | 155 | 2 | GO:1905051 | |
| GeneOntologyBiologicalProcess | DNA ADP-ribosylation | 1.67e-04 | 3 | 155 | 2 | GO:0030592 | |
| GeneOntologyBiologicalProcess | protein localization to plasma membrane | 1.75e-04 | 324 | 155 | 10 | GO:0072659 | |
| GeneOntologyBiologicalProcess | male mating behavior | 1.77e-04 | 15 | 155 | 3 | GO:0060179 | |
| GeneOntologyBiologicalProcess | muscle cell differentiation | FLNC GPER1 YBX1 PARP2 ACTN4 ACTN1 ACTN2 MEF2C MYORG PBRM1 NFATC2 ANKRD17 KDM1A | 1.93e-04 | 531 | 155 | 13 | GO:0042692 |
| GeneOntologyBiologicalProcess | synaptic vesicle recycling | 1.93e-04 | 111 | 155 | 6 | GO:0036465 | |
| GeneOntologyBiologicalProcess | neuron cell-cell adhesion | 2.17e-04 | 16 | 155 | 3 | GO:0007158 | |
| GeneOntologyBiologicalProcess | response to calcium ion | 2.19e-04 | 161 | 155 | 7 | GO:0051592 | |
| GeneOntologyBiologicalProcess | presynapse organization | 2.24e-04 | 73 | 155 | 5 | GO:0099172 | |
| GeneOntologyBiologicalProcess | cellular response to xenobiotic stimulus | 2.82e-04 | 222 | 155 | 8 | GO:0071466 | |
| GeneOntologyBiologicalProcess | glomerulus development | 2.87e-04 | 77 | 155 | 5 | GO:0032835 | |
| GeneOntologyBiologicalProcess | response to jasmonic acid | 3.33e-04 | 4 | 155 | 2 | GO:0009753 | |
| GeneOntologyBiologicalProcess | progesterone catabolic process | 3.33e-04 | 4 | 155 | 2 | GO:0006709 | |
| GeneOntologyBiologicalProcess | C21-steroid hormone catabolic process | 3.33e-04 | 4 | 155 | 2 | GO:0008208 | |
| GeneOntologyBiologicalProcess | regulation of terminal button organization | 3.33e-04 | 4 | 155 | 2 | GO:2000331 | |
| GeneOntologyBiologicalProcess | cellular response to jasmonic acid stimulus | 3.33e-04 | 4 | 155 | 2 | GO:0071395 | |
| GeneOntologyBiologicalProcess | protein localization to cell periphery | GPER1 WASHC1 ACTN2 PICALM AR MAGI2 PACS1 CLTC PALM NUMB GGA1 | 3.58e-04 | 422 | 155 | 11 | GO:1990778 |
| GeneOntologyBiologicalProcess | base-excision repair | 3.92e-04 | 46 | 155 | 4 | GO:0006284 | |
| GeneOntologyBiologicalProcess | sesquiterpenoid catabolic process | 5.53e-04 | 5 | 155 | 2 | GO:0016107 | |
| GeneOntologyBiologicalProcess | olefinic compound catabolic process | 5.53e-04 | 5 | 155 | 2 | GO:0120256 | |
| GeneOntologyBiologicalProcess | farnesol metabolic process | 5.53e-04 | 5 | 155 | 2 | GO:0016487 | |
| GeneOntologyBiologicalProcess | farnesol catabolic process | 5.53e-04 | 5 | 155 | 2 | GO:0016488 | |
| GeneOntologyBiologicalProcess | negative regulation of isoprenoid metabolic process | 5.53e-04 | 5 | 155 | 2 | GO:0045827 | |
| GeneOntologyBiologicalProcess | negative regulation of retinoic acid biosynthetic process | 5.53e-04 | 5 | 155 | 2 | GO:1900053 | |
| GeneOntologyBiologicalProcess | cytoplasmic pattern recognition receptor signaling pathway | 5.59e-04 | 188 | 155 | 7 | GO:0002753 | |
| GeneOntologyBiologicalProcess | progesterone metabolic process | 5.77e-04 | 22 | 155 | 3 | GO:0042448 | |
| GeneOntologyBiologicalProcess | synaptic vesicle clustering | 5.77e-04 | 22 | 155 | 3 | GO:0097091 | |
| GeneOntologyBiologicalProcess | regulation of dendritic spine development | 6.21e-04 | 91 | 155 | 5 | GO:0060998 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | DAB2IP WHRN BCL9L FLNB CHODL ARHGEF18 ACTN1 PICALM AR MEF2C ADD1 SYNGAP1 NLGN3 PTPRS PALM NUMB UNK UNC93B1 CDH7 KDM1A | 6.41e-04 | 1194 | 155 | 20 | GO:0000902 |
| GeneOntologyBiologicalProcess | cellular response to organic cyclic compound | GPER1 TRPM2 AKR1C1 AKR1C2 AR MEF2C ITPR3 PARP1 EGR1 RECQL5 PALM ALK KDM1A | 6.66e-04 | 605 | 155 | 13 | GO:0071407 |
| GeneOntologyBiologicalProcess | xenobiotic metabolic process | 6.96e-04 | 141 | 155 | 6 | GO:0006805 | |
| GeneOntologyBiologicalProcess | vocalization behavior | 7.50e-04 | 24 | 155 | 3 | GO:0071625 | |
| GeneOntologyBiologicalProcess | double-strand break repair | 7.89e-04 | 324 | 155 | 9 | GO:0006302 | |
| GeneOntologyBiologicalProcess | intracellular transport | CTAGE9 SYNRG HHEX RANBP2 SLC66A2 SFPQ SPG7 GPER1 WASHC1 ACTN4 CTAGE6 ACTN2 PICALM NUP155 SMG7 BBS7 CTAGE8 CLTC CTAGE15 UNC93B1 CTAGE4 SDCBP2 GGA1 | 8.08e-04 | 1496 | 155 | 23 | GO:0046907 |
| GeneOntologyBiologicalProcess | sesquiterpenoid metabolic process | 8.25e-04 | 6 | 155 | 2 | GO:0006714 | |
| GeneOntologyBiologicalProcess | polyprenol catabolic process | 8.25e-04 | 6 | 155 | 2 | GO:0016095 | |
| GeneOntologyBiologicalProcess | vascular endothelial growth factor receptor-2 signaling pathway | 8.25e-04 | 6 | 155 | 2 | GO:0036324 | |
| GeneOntologyBiologicalProcess | postsynaptic membrane organization | 8.32e-04 | 56 | 155 | 4 | GO:0001941 | |
| GeneOntologyBiologicalProcess | activation of immune response | DAB2IP CYLD SFPQ RIPK2 BCAR1 MEF2C BLK PARP1 NFATC2 PTPRS ANKRD17 UNC93B1 PUM1 | 8.72e-04 | 623 | 155 | 13 | GO:0002253 |
| GeneOntologyBiologicalProcess | smooth muscle cell differentiation | 9.11e-04 | 99 | 155 | 5 | GO:0051145 | |
| GeneOntologyBiologicalProcess | regulation of ketone biosynthetic process | 9.53e-04 | 26 | 155 | 3 | GO:0010566 | |
| GeneOntologyBiologicalProcess | activation of innate immune response | 9.57e-04 | 333 | 155 | 9 | GO:0002218 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | DAB2IP HHEX KLF8 SFPQ CDX4 SCRT1 YBX1 AR MEF2C MEIS2 PARP1 FOXL2 ZNF608 NFATC2 EGR1 SAMD11 KAT14 KDM1A | 9.63e-04 | 1053 | 155 | 18 | GO:0000122 |
| GeneOntologyBiologicalProcess | immune response-activating signaling pathway | DAB2IP CYLD RIPK2 BCAR1 MEF2C BLK PARP1 NFATC2 PTPRS ANKRD17 UNC93B1 PUM1 | 9.86e-04 | 553 | 155 | 12 | GO:0002757 |
| GeneOntologyBiologicalProcess | cell junction organization | DAB2IP WHRN NLGN4Y ACTN4 ACTN1 ACTN2 PICALM MEF2C ADD1 SYNGAP1 MAGI2 NLGN3 NLGN4X PTPRS PALM NUMB CDH7 | 1.07e-03 | 974 | 155 | 17 | GO:0034330 |
| GeneOntologyBiologicalProcess | presynapse assembly | 1.08e-03 | 60 | 155 | 4 | GO:0099054 | |
| GeneOntologyBiologicalProcess | embryo development | SOX5 WHRN HHEX FRAS1 CDX4 YBX1 CECR2 FBXW4 EXT2 SSBP3 AR MEF2C MEIS2 ADD1 HOXA3 PBRM1 FOXL2 BBS7 UNK KAT14 KDM1A FOXF2 | 1.12e-03 | 1437 | 155 | 22 | GO:0009790 |
| GeneOntologyBiologicalProcess | roof of mouth development | 1.14e-03 | 104 | 155 | 5 | GO:0060021 | |
| GeneOntologyBiologicalProcess | amyloid-beta clearance by transcytosis | 1.15e-03 | 7 | 155 | 2 | GO:0150093 | |
| GeneOntologyBiologicalProcess | response to prostaglandin D | 1.15e-03 | 7 | 155 | 2 | GO:0071798 | |
| GeneOntologyBiologicalProcess | cellular response to prostaglandin D stimulus | 1.15e-03 | 7 | 155 | 2 | GO:0071799 | |
| GeneOntologyBiologicalProcess | regulation of retinoic acid biosynthetic process | 1.15e-03 | 7 | 155 | 2 | GO:1900052 | |
| GeneOntologyBiologicalProcess | connective tissue development | 1.18e-03 | 343 | 155 | 9 | GO:0061448 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA splicing, via spliceosome | 1.19e-03 | 28 | 155 | 3 | GO:0048025 | |
| GeneOntologyCellularComponent | symmetric, GABA-ergic, inhibitory synapse | 1.62e-06 | 4 | 156 | 3 | GO:0098983 | |
| GeneOntologyCellularComponent | somatodendritic compartment | DAB2IP WHRN ZC3H14 FLNB SFPQ GPER1 SLC31A1 YBX1 NLGN4Y TRPM2 ACTN1 ACTN2 PICALM AR ADD1 ITPR3 SYNGAP1 MAGI2 NLGN3 NLGN4X KCNC3 PTPRS PALM NUMB | 1.40e-05 | 1228 | 156 | 24 | GO:0036477 |
| GeneOntologyCellularComponent | endoplasmic reticulum exit site | 1.48e-05 | 42 | 156 | 5 | GO:0070971 | |
| GeneOntologyCellularComponent | dendrite | DAB2IP WHRN ZC3H14 SFPQ GPER1 YBX1 NLGN4Y ACTN1 ACTN2 AR ADD1 ITPR3 SYNGAP1 MAGI2 NLGN3 NLGN4X KCNC3 PALM NUMB | 2.25e-05 | 858 | 156 | 19 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | DAB2IP WHRN ZC3H14 SFPQ GPER1 YBX1 NLGN4Y ACTN1 ACTN2 AR ADD1 ITPR3 SYNGAP1 MAGI2 NLGN3 NLGN4X KCNC3 PALM NUMB | 2.33e-05 | 860 | 156 | 19 | GO:0097447 |
| GeneOntologyCellularComponent | asymmetric synapse | GPR50 GPER1 NLGN4Y ACTN2 PICALM ADD1 SYNGAP1 MAGI2 NLGN3 NLGN4X PTPRS PALM NUMB | 6.22e-05 | 477 | 156 | 13 | GO:0032279 |
| GeneOntologyCellularComponent | postsynaptic specialization | GPR50 GPER1 NLGN4Y ACTN2 PICALM ADD1 SYNGAP1 MAGI2 NLGN3 NLGN4X PTPRS PALM NUMB | 1.06e-04 | 503 | 156 | 13 | GO:0099572 |
| GeneOntologyCellularComponent | symmetric synapse | 1.10e-04 | 13 | 156 | 3 | GO:0032280 | |
| GeneOntologyCellularComponent | postsynaptic density | GPR50 GPER1 NLGN4Y ACTN2 PICALM ADD1 SYNGAP1 MAGI2 NLGN4X PTPRS PALM NUMB | 1.50e-04 | 451 | 156 | 12 | GO:0014069 |
| GeneOntologyCellularComponent | neuron to neuron synapse | GPR50 GPER1 NLGN4Y ACTN2 PICALM ADD1 SYNGAP1 MAGI2 NLGN3 NLGN4X PTPRS PALM NUMB | 1.56e-04 | 523 | 156 | 13 | GO:0098984 |
| GeneOntologyCellularComponent | postsynapse | WHRN GPR50 GPER1 NLGN4Y ACTN4 ACTN1 ACTN2 PICALM MEF2C ADD1 SYNGAP1 MAGI2 NLGN3 NLGN4X KCNC3 PTPRS CLTC PALM NUMB | 2.16e-04 | 1018 | 156 | 19 | GO:0098794 |
| GeneOntologyCellularComponent | chromatin | FOXJ2 SOX5 HHEX KLF8 SFPQ CDX4 CECR2 MCM2 AR MEF2C CASZ1 MEIS2 HOXA3 PARP1 PBRM1 FOXL2 NFATC2 EGR1 ANKRD17 SMARCE1 KAT14 KDM1A FOXF2 HOMEZ | 2.59e-04 | 1480 | 156 | 24 | GO:0000785 |
| GeneOntologyCellularComponent | pseudopodium | 3.06e-04 | 18 | 156 | 3 | GO:0031143 | |
| GeneOntologyCellularComponent | dendritic spine membrane | 3.06e-04 | 18 | 156 | 3 | GO:0032591 | |
| GeneOntologyCellularComponent | asymmetric, glutamatergic, excitatory synapse | 7.35e-04 | 24 | 156 | 3 | GO:0098985 | |
| GeneOntologyCellularComponent | U2AF complex | 1.13e-03 | 7 | 156 | 2 | GO:0089701 | |
| GeneOntologyCellularComponent | nuclear membrane | RANBP2 QRICH2 MYORG ITPR3 NUP155 FAM169A UGT2B15 UGT2B17 ANKRD17 | 1.27e-03 | 349 | 156 | 9 | GO:0031965 |
| GeneOntologyCellularComponent | focal adhesion | 1.52e-03 | 431 | 156 | 10 | GO:0005925 | |
| GeneOntologyCellularComponent | inhibitory synapse | 1.57e-03 | 31 | 156 | 3 | GO:0060077 | |
| GeneOntologyCellularComponent | platelet alpha granule lumen | 1.59e-03 | 67 | 156 | 4 | GO:0031093 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | CYLD WHRN SYNRG RANBP2 CHODL GPER1 YBX1 CNTRL ACTN4 PICALM MEIS2 ADD1 ITPR3 MAGI2 PACS1 TOLLIP | 1.70e-03 | 934 | 156 | 16 | GO:0048471 |
| GeneOntologyCellularComponent | cell-substrate junction | 1.85e-03 | 443 | 156 | 10 | GO:0030055 | |
| GeneOntologyCellularComponent | dendritic spine | 2.31e-03 | 242 | 156 | 7 | GO:0043197 | |
| GeneOntologyCellularComponent | centriolar subdistal appendage | 2.39e-03 | 10 | 156 | 2 | GO:0120103 | |
| GeneOntologyCellularComponent | neuron spine | 2.59e-03 | 247 | 156 | 7 | GO:0044309 | |
| MousePheno | elevated level of mitotic sister chromatid exchange | 8.97e-06 | 16 | 121 | 4 | MP:0003701 | |
| Domain | ACTININ_2 | 8.76e-07 | 23 | 148 | 5 | PS00020 | |
| Domain | ACTININ_1 | 8.76e-07 | 23 | 148 | 5 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 8.76e-07 | 23 | 148 | 5 | IPR001589 | |
| Domain | Nlgn | 4.82e-06 | 5 | 148 | 3 | IPR000460 | |
| Domain | EFhand_Ca_insen | 9.58e-06 | 6 | 148 | 3 | PF08726 | |
| Domain | EF-hand_Ca_insen | 9.58e-06 | 6 | 148 | 3 | IPR014837 | |
| Domain | NLGN4 | 6.24e-05 | 2 | 148 | 2 | IPR030025 | |
| Domain | Carboxylesterase_B_CS | 1.32e-04 | 13 | 148 | 3 | IPR019819 | |
| Domain | CH | 1.65e-04 | 65 | 148 | 5 | SM00033 | |
| Domain | CARBOXYLESTERASE_B_2 | 1.66e-04 | 14 | 148 | 3 | PS00941 | |
| Domain | COesterase | 1.66e-04 | 14 | 148 | 3 | PF00135 | |
| Domain | CarbesteraseB | 1.66e-04 | 14 | 148 | 3 | IPR002018 | |
| Domain | WGR | 1.86e-04 | 3 | 148 | 2 | SM00773 | |
| Domain | PARP_reg | 1.86e-04 | 3 | 148 | 2 | PF02877 | |
| Domain | DUF3498 | 1.86e-04 | 3 | 148 | 2 | IPR021887 | |
| Domain | WGR | 1.86e-04 | 3 | 148 | 2 | PF05406 | |
| Domain | SSDP_DNA-bd | 1.86e-04 | 3 | 148 | 2 | IPR008116 | |
| Domain | DUF3498 | 1.86e-04 | 3 | 148 | 2 | PF12004 | |
| Domain | - | 1.86e-04 | 3 | 148 | 2 | 2.20.140.10 | |
| Domain | CH | 2.34e-04 | 70 | 148 | 5 | PF00307 | |
| Domain | - | 2.50e-04 | 71 | 148 | 5 | 1.10.418.10 | |
| Domain | CH | 2.84e-04 | 73 | 148 | 5 | PS50021 | |
| Domain | CH-domain | 3.23e-04 | 75 | 148 | 5 | IPR001715 | |
| Domain | SUZ | 3.70e-04 | 4 | 148 | 2 | IPR024771 | |
| Domain | PARP_ALPHA_HD | 3.70e-04 | 4 | 148 | 2 | PS51060 | |
| Domain | Poly(ADP-ribose)pol_reg_dom | 3.70e-04 | 4 | 148 | 2 | IPR004102 | |
| Domain | SUZ | 3.70e-04 | 4 | 148 | 2 | PS51673 | |
| Domain | - | 3.70e-04 | 4 | 148 | 2 | 1.20.142.10 | |
| Domain | NUT | 6.14e-04 | 5 | 148 | 2 | IPR024310 | |
| Domain | NUT_N | 6.14e-04 | 5 | 148 | 2 | IPR024309 | |
| Domain | NUT | 6.14e-04 | 5 | 148 | 2 | PF12881 | |
| Domain | Spectrin | 7.69e-04 | 23 | 148 | 3 | PF00435 | |
| Domain | Spectrin_repeat | 1.53e-03 | 29 | 148 | 3 | IPR002017 | |
| Domain | SPEC | 2.04e-03 | 32 | 148 | 3 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 2.04e-03 | 32 | 148 | 3 | IPR018159 | |
| Domain | R3H | 2.16e-03 | 9 | 148 | 2 | SM00393 | |
| Domain | ALDOKETO_REDUCTASE_1 | 2.69e-03 | 10 | 148 | 2 | PS00798 | |
| Domain | IG_FLMN | 2.69e-03 | 10 | 148 | 2 | SM00557 | |
| Domain | ALDOKETO_REDUCTASE_2 | 2.69e-03 | 10 | 148 | 2 | PS00062 | |
| Domain | ALDOKETO_REDUCTASE_3 | 2.69e-03 | 10 | 148 | 2 | PS00063 | |
| Domain | Aldo/ket_reductase_CS | 2.69e-03 | 10 | 148 | 2 | IPR018170 | |
| Domain | Aldo/keto_reductase | 2.69e-03 | 10 | 148 | 2 | IPR020471 | |
| Domain | Filamin | 3.27e-03 | 11 | 148 | 2 | PF00630 | |
| Domain | R3H | 3.27e-03 | 11 | 148 | 2 | PS51061 | |
| Domain | FILAMIN_REPEAT | 3.27e-03 | 11 | 148 | 2 | PS50194 | |
| Domain | Filamin/ABP280_rpt | 3.27e-03 | 11 | 148 | 2 | IPR001298 | |
| Domain | Filamin/ABP280_repeat-like | 3.27e-03 | 11 | 148 | 2 | IPR017868 | |
| Domain | R3H | 3.27e-03 | 11 | 148 | 2 | PF01424 | |
| Domain | - | 3.27e-03 | 11 | 148 | 2 | 3.30.1370.50 | |
| Domain | R3H_dom | 3.27e-03 | 11 | 148 | 2 | IPR001374 | |
| Domain | RasGAP | 5.33e-03 | 14 | 148 | 2 | SM00323 | |
| Domain | RasGAP_CS | 5.33e-03 | 14 | 148 | 2 | IPR023152 | |
| Domain | TF_fork_head_CS_2 | 5.77e-03 | 46 | 148 | 3 | IPR030456 | |
| Domain | RasGAP | 6.12e-03 | 15 | 148 | 2 | PF00616 | |
| Domain | RAS_GTPASE_ACTIV_1 | 6.12e-03 | 15 | 148 | 2 | PS00509 | |
| Domain | RAS_GTPASE_ACTIV_2 | 6.12e-03 | 15 | 148 | 2 | PS50018 | |
| Domain | TF_fork_head_CS_1 | 6.13e-03 | 47 | 148 | 3 | IPR018122 | |
| Domain | ZnF_C3H1 | 6.50e-03 | 48 | 148 | 3 | SM00356 | |
| Domain | FH | 6.88e-03 | 49 | 148 | 3 | SM00339 | |
| Domain | FORK_HEAD_1 | 6.88e-03 | 49 | 148 | 3 | PS00657 | |
| Domain | FORK_HEAD_2 | 6.88e-03 | 49 | 148 | 3 | PS00658 | |
| Domain | Fork_head_dom | 6.88e-03 | 49 | 148 | 3 | IPR001766 | |
| Domain | FORK_HEAD_3 | 6.88e-03 | 49 | 148 | 3 | PS50039 | |
| Domain | Forkhead | 6.88e-03 | 49 | 148 | 3 | PF00250 | |
| Domain | - | 6.96e-03 | 16 | 148 | 2 | 1.10.506.10 | |
| Domain | - | 6.96e-03 | 16 | 148 | 2 | 3.20.20.100 | |
| Domain | NADP_OxRdtase_dom | 7.85e-03 | 17 | 148 | 2 | IPR023210 | |
| Domain | Poly(ADP-ribose)pol_cat_dom | 7.85e-03 | 17 | 148 | 2 | IPR012317 | |
| Domain | PARP_CATALYTIC | 7.85e-03 | 17 | 148 | 2 | PS51059 | |
| Domain | Homeobox_KN | 7.85e-03 | 17 | 148 | 2 | PF05920 | |
| Domain | PARP | 7.85e-03 | 17 | 148 | 2 | PF00644 | |
| Domain | Homeobox_KN_domain | 7.85e-03 | 17 | 148 | 2 | IPR008422 | |
| Domain | - | 7.85e-03 | 17 | 148 | 2 | 3.90.228.10 | |
| Domain | Aldo_ket_red | 7.85e-03 | 17 | 148 | 2 | PF00248 | |
| Domain | Aldo/ket_red/Kv-b | 7.85e-03 | 17 | 148 | 2 | IPR001395 | |
| Domain | AMP-bd_C | 7.85e-03 | 17 | 148 | 2 | IPR025110 | |
| Domain | AMP-binding_C | 7.85e-03 | 17 | 148 | 2 | PF13193 | |
| Pathway | REACTOME_PREDNISONE_ADME | 2.77e-05 | 23 | 110 | 4 | MM16639 | |
| Pathway | REACTOME_NEPHRIN_FAMILY_INTERACTIONS | 2.77e-05 | 23 | 110 | 4 | M913 | |
| Pathway | WP_NPHP1_DELETION_SYNDROME | 7.29e-05 | 11 | 110 | 3 | M48099 | |
| Pathway | BIOCARTA_CELL2CELL_PATHWAY | 9.66e-05 | 12 | 110 | 3 | M12851 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | FLNB KLF8 HIVEP2 SLC31A1 NLGN4Y POLG TRPM2 HECTD4 U2AF2 ARHGEF18 BCAR1 SSBP3 TEP1 NAALADL2 AR CASZ1 CEP170 PACS1 NLGN3 SMG7 FAM168A ZNF608 SH3TC1 PTPRS ANKRD17 NUMB TET3 | 8.06e-10 | 1489 | 158 | 27 | 28611215 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | DAB2IP SYNRG FLNC FRAS1 HIVEP2 SPG7 POLG HECTD4 C19orf47 MUS81 C15orf39 ATG2A TEP1 CASZ1 MYORG ITPR3 SH3TC1 ZNF341 PTPRS PALM SSBP4 PUM1 GGA1 | 1.27e-09 | 1105 | 158 | 23 | 35748872 |
| Pubmed | DAB2IP CYLD FLNB AMPD2 SFPQ AOC1 SPG7 TAGAP POLG CNTRL ARHGEF18 ACTN4 AKR1C1 AKR1C2 PACS1 NLGN3 FAM168A ZNF341 CLTC TOLLIP ANKRD17 PUM1 | 4.76e-09 | 1084 | 158 | 22 | 11544199 | |
| Pubmed | SOX5 CYLD BCL9L KLF8 ADRM1 YBX1 C15orf39 R3HDM2 SSBP3 MEF2C PBRM1 SMG7 ZNF608 SAMD11 RECQL5 ANKRD17 UNK HELZ SMARCE1 SSBP4 R3HDM1 PUM1 KAT14 KDM1A HOMEZ | 7.55e-09 | 1429 | 158 | 25 | 35140242 | |
| Pubmed | ZC3H14 FLNB FLNC RANBP2 SFPQ U2AF2 ACTN4 ACTN1 ITPR3 CEP170 PBRM1 NUP155 CLTC ANKRD17 HELZ PUM1 KDM1A | 8.61e-09 | 653 | 158 | 17 | 22586326 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | ZC3H14 FLNB FLNC RANBP2 SFPQ YBX1 C19orf47 U2AF2 MCM2 ACTN4 ACTN1 SF1 ITPR3 CEP170 PARP1 PBRM1 NUP155 BBS7 CLTC PUM1 KDM1A | 9.20e-09 | 1024 | 158 | 21 | 24711643 |
| Pubmed | DAB2IP CYLD AMPD2 RANBP2 SFPQ HECTD4 RIPK2 ARHGEF18 PICALM ADD1 SYNGAP1 CEP170 MAGI2 NLGN3 PARP1 PBRM1 PTPRS CLTC ANKRD17 KDM1A | 1.74e-08 | 963 | 158 | 20 | 28671696 | |
| Pubmed | FLNC RANBP2 SFPQ HIVEP2 CNTRL ACTN4 ACTN1 MEF2C EGR1 CLTC TOLLIP ANKRD17 HELZ WASH2P | 5.51e-08 | 486 | 158 | 14 | 20936779 | |
| Pubmed | ZC3H14 FLNB SFPQ ACTN4 ACTN1 ADD1 CEP170 PARP1 CLTC R3HDM1 PUM1 | 5.74e-08 | 274 | 158 | 11 | 34244482 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | SOX5 BCL9L RANBP2 HIVEP2 C15orf39 PBRM1 ZNF608 ASXL3 SMARCE1 KAT14 KDM1A HOMEZ | 8.16e-08 | 351 | 158 | 12 | 38297188 |
| Pubmed | 9.20e-08 | 3 | 158 | 3 | 32011705 | ||
| Pubmed | 9.20e-08 | 3 | 158 | 3 | 18628683 | ||
| Pubmed | Androgen receptor mediates the expression of UDP-glucuronosyltransferase 2 B15 and B17 genes. | 9.20e-08 | 3 | 158 | 3 | 18302198 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | CYLD ZC3H14 SYNRG FLNC RANBP2 U2AF2 SF1 ADD1 CEP170 SCCPDH SMG7 ANKRD17 UNK HELZ R3HDM1 PUM1 | 2.24e-07 | 724 | 158 | 16 | 36232890 |
| Pubmed | DAB2IP CYLD BCL9L SYNRG FLNB AMPD2 RANBP2 SFPQ ADRM1 YBX1 PDHB ACTN4 SYNGAP1 CEP170 MAGI2 ISOC2 CLTC FAM169A PALM HELZ | 2.61e-07 | 1139 | 158 | 20 | 36417873 | |
| Pubmed | 3.67e-07 | 4 | 158 | 3 | 1629252 | ||
| Pubmed | Cell death and autophagy under oxidative stress: roles of poly(ADP-Ribose) polymerases and Ca(2+). | 3.67e-07 | 4 | 158 | 3 | 22751932 | |
| Pubmed | Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. | 3.67e-07 | 4 | 158 | 3 | 12669065 | |
| Pubmed | Homodimerization and isoform-specific heterodimerization of neuroligins. | 3.67e-07 | 4 | 158 | 3 | 22671294 | |
| Pubmed | 3.67e-07 | 4 | 158 | 3 | 20579107 | ||
| Pubmed | 3.67e-07 | 4 | 158 | 3 | 16807302 | ||
| Pubmed | 3.67e-07 | 4 | 158 | 3 | 16077734 | ||
| Pubmed | 3.67e-07 | 4 | 158 | 3 | 17292328 | ||
| Pubmed | 3.67e-07 | 4 | 158 | 3 | 18281521 | ||
| Pubmed | FLNB FLNC RANBP2 SFPQ GPR50 YBX1 PDHB ACTN4 ACTN1 PARP1 ISOC2 NUP155 CLTC | 3.71e-07 | 484 | 158 | 13 | 31995728 | |
| Pubmed | DAB2IP CYLD WHRN FRAS1 R3HDM2 CSMD3 MAGI2 FAM168A CLTC R3HDM1 PUM1 TET3 | 3.98e-07 | 407 | 158 | 12 | 12693553 | |
| Pubmed | FLNB FLNC RANBP2 SFPQ YBX1 PDHB CNTRL U2AF2 ACTN4 CTAGE6 ACTN1 ACTN2 GPALPP1 PARP1 SCCPDH ZNF608 CTAGE8 CLTC FAM169A PALM CTAGE15 CTAGE4 | 6.77e-07 | 1442 | 158 | 22 | 35575683 | |
| Pubmed | Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome. | 7.87e-07 | 219 | 158 | 9 | 31353912 | |
| Pubmed | Synaptopodin regulates the actin-bundling activity of alpha-actinin in an isoform-specific manner. | 9.14e-07 | 5 | 158 | 3 | 15841212 | |
| Pubmed | The adenosine A2A receptor interacts with the actin-binding protein alpha-actinin. | 9.14e-07 | 5 | 158 | 3 | 12837758 | |
| Pubmed | 9.14e-07 | 5 | 158 | 3 | 37865312 | ||
| Pubmed | 9.14e-07 | 5 | 158 | 3 | 19943616 | ||
| Pubmed | Synapse formation: if it looks like a duck and quacks like a duck ... | 9.14e-07 | 5 | 158 | 3 | 10996085 | |
| Pubmed | CECR2 HECTD4 MCM2 ATG2A NUP155 SMG7 USP38 ZNF608 PALM ANKRD17 UNK KDM1A HOMEZ | 1.00e-06 | 529 | 158 | 13 | 14621295 | |
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | ZC3H14 RANBP2 SFPQ ADRM1 YBX1 PDHB FAM221A PARP2 MCM2 ACTN4 BCAR1 SSBP3 SCCPDH CLTC HELZ PUM1 FOXF2 | 1.14e-06 | 922 | 158 | 17 | 27609421 |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | FLNB RANBP2 SFPQ CDX4 YBX1 U2AF2 ACTN4 ACTN1 BCAR1 CASZ1 ITPR3 CEP170 PARP1 CLTC | 1.15e-06 | 626 | 158 | 14 | 33644029 |
| Pubmed | A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase. | 1.27e-06 | 232 | 158 | 9 | 25515538 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ZC3H14 SYNRG RANBP2 SFPQ PICALM SF1 ADD1 GPALPP1 CEP170 PARP1 SMG7 FAM169A PPME1 ANKRD17 NUMB HELZ SMARCE1 | 1.36e-06 | 934 | 158 | 17 | 33916271 |
| Pubmed | FLNB RANBP2 SFPQ PDHB MCM2 ACTN4 ACTN1 PICALM ADD1 PARP1 NUP155 CLTC PUM1 KDM1A | 1.44e-06 | 638 | 158 | 14 | 33239621 | |
| Pubmed | DAB2IP RANBP2 PDHB ACTN4 BCAR1 ITPR3 PACS1 PARP1 SCCPDH NUP155 SMG7 PTPRS CLTC PPME1 PALM NUMB HELZ PUM1 | 1.50e-06 | 1049 | 158 | 18 | 27880917 | |
| Pubmed | Identification of Novel Nuclear Factor of Activated T Cell (NFAT)-associated Proteins in T Cells. | 1.68e-06 | 178 | 158 | 8 | 27637333 | |
| Pubmed | Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration. | SYNRG FLNC SFPQ ADRM1 YBX1 PDHB ACTN1 ADD1 CEP170 PARP1 CLTC TOLLIP NUMB | 1.81e-06 | 558 | 158 | 13 | 35063084 |
| Pubmed | 1.82e-06 | 6 | 158 | 3 | 21838267 | ||
| Pubmed | 1.82e-06 | 6 | 158 | 3 | 18425115 | ||
| Pubmed | 1.82e-06 | 6 | 158 | 3 | 22693585 | ||
| Pubmed | MEF2 and NR2F2 cooperate to regulate Akr1c14 gene expression in mouse MA-10 Leydig cells. | 1.82e-06 | 6 | 158 | 3 | 26748576 | |
| Pubmed | Molecular basis for autoregulatory interaction between GAE domain and hinge region of GGA1. | 1.82e-06 | 6 | 158 | 3 | 17506864 | |
| Pubmed | 1.82e-06 | 6 | 158 | 3 | 29724786 | ||
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 1.83e-06 | 180 | 158 | 8 | 35198878 | |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | DAB2IP SOX5 FLNB SFPQ YBX1 PDHB FAM221A CNTRL ACTN1 ACTN2 SYNGAP1 NLGN3 R3HDM1 | 1.88e-06 | 560 | 158 | 13 | 21653829 |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | ZC3H14 FLNB FLNC RANBP2 SFPQ ADRM1 YBX1 MCM2 ACTN4 PARP1 NUP155 CLTC | 2.09e-06 | 477 | 158 | 12 | 31300519 |
| Pubmed | 3.18e-06 | 7 | 158 | 3 | 11724819 | ||
| Pubmed | 3.18e-06 | 7 | 158 | 3 | 26160177 | ||
| Pubmed | 3.18e-06 | 7 | 158 | 3 | 16337335 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | CYLD SYNRG C19orf47 C15orf39 BCAR1 BLK SMG7 RECQL5 CLTC UNK HELZ KAT14 KDM1A | 3.20e-06 | 588 | 158 | 13 | 38580884 |
| Pubmed | 3.32e-06 | 334 | 158 | 10 | 30425250 | ||
| Pubmed | 3.58e-06 | 197 | 158 | 8 | 21386911 | ||
| Pubmed | A census of human transcription factors: function, expression and evolution. | FOXJ2 SOX5 HHEX KLF8 CDX4 HIVEP2 YBX1 AR MEF2C MEIS2 HOXA3 FOXL2 NFATC2 EGR1 FOXF2 HOMEZ | 4.25e-06 | 908 | 158 | 16 | 19274049 |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | ARHGEF18 ATG2A BCAR1 PICALM SYNGAP1 NUP155 EGR1 CLTC NUMB UNK SDCBP2 | 4.80e-06 | 430 | 158 | 11 | 35044719 |
| Pubmed | 5.07e-06 | 8 | 158 | 3 | 33584538 | ||
| Pubmed | CHAP is a newly identified Z-disc protein essential for heart and skeletal muscle function. | 5.07e-06 | 8 | 158 | 3 | 20215401 | |
| Pubmed | Neuroligin-1 Signaling Controls LTP and NMDA Receptors by Distinct Molecular Pathways. | 5.07e-06 | 8 | 158 | 3 | 30871858 | |
| Pubmed | Mice deficient in alpha-actinin-4 have severe glomerular disease. | 5.07e-06 | 8 | 158 | 3 | 12782671 | |
| Pubmed | 5.22e-06 | 147 | 158 | 7 | 16959763 | ||
| Pubmed | 5.26e-06 | 55 | 158 | 5 | 31640799 | ||
| Pubmed | SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes. | 5.41e-06 | 353 | 158 | 10 | 27545878 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | RANBP2 HECTD4 MCM2 ITPR3 CEP170 PARP1 PBRM1 NUP155 CLTC ANKRD17 KDM1A | 5.97e-06 | 440 | 158 | 11 | 34244565 |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | DAB2IP NLGN4Y ARHGEF18 ACTN4 ACTN1 SYNGAP1 NLGN3 NLGN4X CLTC | 6.06e-06 | 281 | 158 | 9 | 28706196 |
| Pubmed | 6.28e-06 | 57 | 158 | 5 | 21368052 | ||
| Pubmed | 6.51e-06 | 152 | 158 | 7 | 38360978 | ||
| Pubmed | TTF-1/NKX2-1 binds to DDB1 and confers replication stress resistance to lung adenocarcinomas. | 6.51e-06 | 152 | 158 | 7 | 28192407 | |
| Pubmed | CYLD FLNB HIVEP2 PDHB POLG HECTD4 FBXW4 ACTN4 ZNF619 ACTN1 SF1 SYNGAP1 MAGI2 PARP1 CLTC TOLLIP PPME1 SMARCE1 R3HDM1 | 6.52e-06 | 1285 | 158 | 19 | 35914814 | |
| Pubmed | The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis. | 7.53e-06 | 218 | 158 | 8 | 33378226 | |
| Pubmed | 7.57e-06 | 9 | 158 | 3 | 23010509 | ||
| Pubmed | EpsinR: an AP1/clathrin interacting protein involved in vesicle trafficking. | 7.57e-06 | 9 | 158 | 3 | 12538641 | |
| Pubmed | 7.71e-06 | 28 | 158 | 4 | 30947518 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | ZC3H14 RANBP2 ZNF777 SFPQ YBX1 U2AF2 PICALM SF1 CEP170 PARP1 FAM168A RECQL5 CLTC SMARCE1 PUM1 ALK | 7.89e-06 | 954 | 158 | 16 | 36373674 |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 8.05e-06 | 220 | 158 | 8 | 35785414 | |
| Pubmed | 8.11e-06 | 60 | 158 | 5 | 19075228 | ||
| Pubmed | 8.95e-06 | 295 | 158 | 9 | 26209609 | ||
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | FLNB FLNC RANBP2 ADRM1 PDHB MCM2 ACTN4 EXT2 PICALM MYORG ITPR3 NUP155 PTPRS ANKRD17 HELZ KDM1A | 1.02e-05 | 974 | 158 | 16 | 28675297 |
| Pubmed | Tropomodulin isoforms regulate thin filament pointed-end capping and skeletal muscle physiology. | 1.08e-05 | 10 | 158 | 3 | 20368620 | |
| Pubmed | Large-scale phosphomimetic screening identifies phospho-modulated motif-based protein interactions. | 1.16e-05 | 110 | 158 | 6 | 37219487 | |
| Pubmed | 1.20e-05 | 65 | 158 | 5 | 34645483 | ||
| Pubmed | ZC3H14 RANBP2 SFPQ YBX1 C15orf39 ACTN4 ACTN1 SF1 GPALPP1 CEP170 PARP1 EGR1 CLTC PPME1 SMARCE1 KDM1A HOMEZ | 1.21e-05 | 1103 | 158 | 17 | 34189442 | |
| Pubmed | CYLD FLNB ADRM1 HECTD4 ACTN4 ACTN1 ITPR3 SCCPDH USP38 TOLLIP GGA1 | 1.37e-05 | 481 | 158 | 11 | 28190767 | |
| Pubmed | 1.48e-05 | 11 | 158 | 3 | 11842093 | ||
| Pubmed | 1.48e-05 | 11 | 158 | 3 | 32973045 | ||
| Pubmed | 1.48e-05 | 11 | 158 | 3 | 26403076 | ||
| Pubmed | RANBP2 MCM2 ACTN4 ACTN1 PARP1 SCCPDH NUP155 CLTC SMARCE1 KDM1A | 1.56e-05 | 399 | 158 | 10 | 37536630 | |
| Pubmed | FLNB SFPQ YBX1 MCM2 ACTN4 PICALM SF1 PARP1 CLTC ANKRD17 PUM1 | 1.66e-05 | 491 | 158 | 11 | 22623428 | |
| Pubmed | FLNB FLNC RANBP2 SFPQ ACTN4 ZNF619 ACTN2 AKR1C2 SF1 CEP170 CLTC | 1.85e-05 | 497 | 158 | 11 | 23414517 | |
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 1.90e-05 | 120 | 158 | 6 | 31413325 | |
| Pubmed | Phosphorylation of mouse LASP-1 on threonine 156 by cAMP- and cGMP-dependent protein kinase. | 1.96e-05 | 12 | 158 | 3 | 15465019 | |
| Pubmed | Timing of adrenal regression controlled by synergistic interaction between Sf1 SUMOylation and Dax1. | 1.96e-05 | 12 | 158 | 3 | 28893949 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | FLNB FLNC RANBP2 SFPQ ADRM1 YBX1 PDHB U2AF2 MCM2 ACTN4 ACTN1 SF1 ADD1 CEP170 PARP1 CLTC ANKRD17 | 2.04e-05 | 1149 | 158 | 17 | 35446349 |
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 32705175 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 25482560 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 27782075 | ||
| Pubmed | 2.05e-05 | 2 | 158 | 2 | 8573067 | ||
| Interaction | SMAP2 interactions | SYNRG R3HDM2 PICALM CEP170 SMG7 FAM168A NUMB UNK HELZ R3HDM1 PUM1 RBM47 GGA1 | 2.37e-09 | 189 | 154 | 13 | int:SMAP2 |
| Interaction | TOP3B interactions | DAB2IP SYNRG FLNC FRAS1 HIVEP2 SPG7 YBX1 POLG HECTD4 C19orf47 MUS81 C15orf39 R3HDM2 ACTN4 ACTN1 ATG2A TEP1 CASZ1 MYORG ITPR3 SMG7 SH3TC1 ZNF341 PTPRS RECQL5 PALM ANKRD17 UNK HELZ SSBP4 PUM1 RBM47 GGA1 | 1.61e-08 | 1470 | 154 | 33 | int:TOP3B |
| Interaction | PRRC2B interactions | KLF8 CECR2 R3HDM2 PICALM AR SF1 SMG7 ANKRD17 UNK HELZ R3HDM1 PUM1 RBM47 | 1.32e-07 | 265 | 154 | 13 | int:PRRC2B |
| Interaction | TNRC6A interactions | CYLD SFPQ CNTRL R3HDM2 PICALM NUP155 SMG7 CLTC ANKRD17 UNK HELZ PUM1 KDM1A | 2.49e-07 | 280 | 154 | 13 | int:TNRC6A |
| Interaction | FUBP3 interactions | U2AF2 MCM2 R3HDM2 AR SF1 FOXL2 SMG7 ANKRD17 UNK HELZ R3HDM1 PUM1 RBM47 | 4.87e-07 | 297 | 154 | 13 | int:FUBP3 |
| Interaction | CTAGE1 interactions | 6.64e-07 | 10 | 154 | 4 | int:CTAGE1 | |
| Interaction | FMR1 interactions | CYLD RANBP2 SFPQ YBX1 CECR2 RIPK2 ARHGEF18 ACTN4 SYNGAP1 CEP170 PBRM1 SMG7 ANKRD17 UNK R3HDM1 PUM1 KDM1A | 7.77e-07 | 536 | 154 | 17 | int:FMR1 |
| Interaction | PHB2 interactions | SOX5 CYLD KLF8 PDHB RIPK2 U2AF2 MCM2 ATG2A AR MEF2C ITPR3 BLK SCCPDH ASXL3 CLTC UNK UNC93B1 | 8.60e-07 | 540 | 154 | 17 | int:PHB2 |
| Interaction | ALG13 interactions | 1.48e-06 | 183 | 154 | 10 | int:ALG13 | |
| Interaction | TNRC6B interactions | CYLD CNTRL R3HDM2 NUP155 SMG7 CLTC ANKRD17 UNK HELZ PUM1 RBM47 KDM1A | 1.83e-06 | 282 | 154 | 12 | int:TNRC6B |
| Interaction | OTUD4 interactions | CYLD FLNC R3HDM2 PARP1 SMG7 ANKRD17 UNK HELZ R3HDM1 PUM1 RBM47 | 2.08e-06 | 236 | 154 | 11 | int:OTUD4 |
| Interaction | YWHAZ interactions | DAB2IP CYLD SYNRG AMPD2 SFPQ HIVEP2 PDHB HECTD4 U2AF2 ARHGEF18 MCM2 R3HDM2 BCAR1 AR MEF2C SYNGAP1 CEP170 PACS1 NFATC2 ASXL3 CLTC ANKRD17 NUMB UNK R3HDM1 PUM1 HOMEZ | 2.41e-06 | 1319 | 154 | 27 | int:YWHAZ |
| Interaction | CLTC interactions | CYLD RANBP2 ADRM1 CNTRL U2AF2 MCM2 ACTN4 ACTN1 PICALM AR SYNGAP1 CLTC TOLLIP PPME1 NUMB UNK HELZ GGA1 | 2.78e-06 | 655 | 154 | 18 | int:CLTC |
| Interaction | PHIP interactions | CECR2 BCAR1 CEP170 PARP1 PBRM1 SMG7 ZNF608 EGR1 ANKRD17 HELZ | 2.87e-06 | 197 | 154 | 10 | int:PHIP |
| Interaction | YTHDF3 interactions | KLF8 MCM2 R3HDM2 SF1 SMG7 ANKRD17 UNK HELZ R3HDM1 PUM1 RBM47 | 3.10e-06 | 246 | 154 | 11 | int:YTHDF3 |
| Interaction | YWHAE interactions | DAB2IP CYLD SYNRG AMPD2 SFPQ HIVEP2 YBX1 PDHB RIPK2 U2AF2 MCM2 R3HDM2 ACTN4 BCAR1 HIBADH SYNGAP1 CEP170 PACS1 NFATC2 SAMD11 CLTC ANKRD17 NUMB UNK R3HDM1 PUM1 | 3.12e-06 | 1256 | 154 | 26 | int:YWHAE |
| Interaction | UNK interactions | SFPQ YBX1 BCAR1 PICALM NUP155 SMG7 CLTC ANKRD17 UNK HELZ PNRC1 R3HDM1 PUM1 KDM1A | 3.13e-06 | 408 | 154 | 14 | int:UNK |
| Interaction | CPEB4 interactions | 3.22e-06 | 156 | 154 | 9 | int:CPEB4 | |
| Interaction | R3HDM1 interactions | 3.67e-06 | 84 | 154 | 7 | int:R3HDM1 | |
| Interaction | YTHDF1 interactions | MCM2 SF1 BLK SMG7 FAM168A TOLLIP ANKRD17 UNK HELZ R3HDM1 PUM1 RBM47 | 3.71e-06 | 302 | 154 | 12 | int:YTHDF1 |
| Interaction | CNOT1 interactions | RIPK2 MCM2 R3HDM2 BLK NUP155 SMG7 TOLLIP ANKRD17 UNK HELZ PUM1 KDM1A | 4.11e-06 | 305 | 154 | 12 | int:CNOT1 |
| Interaction | ATXN1 interactions | FLNB KLF8 RANBP2 SFPQ ADRM1 PDHB U2AF2 MCM2 R3HDM2 ACTN2 PICALM AR SF1 NLGN3 NUP155 FAM168A TOLLIP UNK SMARCE1 R3HDM1 PUM1 SDCBP2 KDM1A | 4.18e-06 | 1039 | 154 | 23 | int:ATXN1 |
| Interaction | YWHAQ interactions | DAB2IP CYLD SYNRG AMPD2 HIVEP2 ADRM1 HECTD4 RIPK2 C19orf47 MCM2 R3HDM2 ACTN2 BCAR1 HIBADH AR CEP170 NFATC2 SAMD11 CLTC ANKRD17 NUMB R3HDM1 PUM1 HOMEZ | 4.26e-06 | 1118 | 154 | 24 | int:YWHAQ |
| Interaction | HELZ interactions | C15orf39 R3HDM2 NUP155 SMG7 CLTC ANKRD17 UNK HELZ R3HDM1 PUM1 RBM47 | 4.72e-06 | 257 | 154 | 11 | int:HELZ |
| Interaction | ATXN2 interactions | YBX1 R3HDM2 ACTN4 ACTN1 ACTN2 SMG7 ANKRD17 UNK HELZ R3HDM1 PUM1 RBM47 | 5.18e-06 | 312 | 154 | 12 | int:ATXN2 |
| Interaction | YTHDF2 interactions | CYLD KLF8 SFPQ MCM2 R3HDM2 SMG7 ANKRD17 UNK HELZ R3HDM1 PUM1 RBM47 | 5.18e-06 | 312 | 154 | 12 | int:YTHDF2 |
| Interaction | LSM14A interactions | 5.27e-06 | 260 | 154 | 11 | int:LSM14A | |
| Interaction | GARRE1 interactions | 5.63e-06 | 167 | 154 | 9 | int:GARRE1 | |
| Interaction | CAPZA2 interactions | CYLD FLNB PDHB MCM2 ACTN4 ACTN1 PICALM AR ADD1 ITPR3 PARP1 ASXL3 CLTC NUMB | 5.73e-06 | 430 | 154 | 14 | int:CAPZA2 |
| Interaction | CEP85 interactions | 6.20e-06 | 169 | 154 | 9 | int:CEP85 | |
| Interaction | UBAP2 interactions | 6.50e-06 | 170 | 154 | 9 | int:UBAP2 | |
| Interaction | TIMM23B interactions | 6.59e-06 | 35 | 154 | 5 | int:TIMM23B | |
| Interaction | TLE3 interactions | FOXJ2 BCL9L HHEX HIVEP2 CECR2 C15orf39 AR SMG7 ZNF608 EGR1 HELZ SSBP4 KDM1A | 6.59e-06 | 376 | 154 | 13 | int:TLE3 |
| Interaction | YWHAG interactions | DAB2IP CYLD SYNRG AMPD2 HIVEP2 HECTD4 RIPK2 C19orf47 MCM2 R3HDM2 ACTN4 BCAR1 SYNGAP1 CEP170 PACS1 NFATC2 SAMD11 CLTC ANKRD17 NUMB UNK HELZ R3HDM1 PUM1 HOMEZ | 8.76e-06 | 1248 | 154 | 25 | int:YWHAG |
| Interaction | NFIX interactions | 1.01e-05 | 227 | 154 | 10 | int:NFIX | |
| Interaction | YWHAH interactions | DAB2IP CYLD ZC3H14 SYNRG AMPD2 HIVEP2 CNTRL HECTD4 RIPK2 C19orf47 FBXW4 MCM2 R3HDM2 BCAR1 SYNGAP1 CEP170 PACS1 SAMD11 ANKRD17 NUMB R3HDM1 PUM1 HOMEZ | 1.09e-05 | 1102 | 154 | 23 | int:YWHAH |
| Interaction | TNRC6C interactions | 1.11e-05 | 138 | 154 | 8 | int:TNRC6C | |
| Interaction | CCDC8 interactions | ZC3H14 FLNB RANBP2 SFPQ YBX1 C19orf47 FBXW4 MCM2 ACTN4 SF1 ITPR3 CEP170 PARP1 NUP155 BBS7 CLTC PUM1 | 1.15e-05 | 656 | 154 | 17 | int:CCDC8 |
| Interaction | LHX9 interactions | 1.44e-05 | 20 | 154 | 4 | int:LHX9 | |
| Interaction | PRRC2C interactions | 1.47e-05 | 290 | 154 | 11 | int:PRRC2C | |
| Interaction | DAZL interactions | 1.59e-05 | 145 | 154 | 8 | int:DAZL | |
| Interaction | LARP4B interactions | 1.63e-05 | 240 | 154 | 10 | int:LARP4B | |
| Interaction | CPEB1 interactions | 1.68e-05 | 146 | 154 | 8 | int:CPEB1 | |
| Interaction | PSMB5 interactions | 1.75e-05 | 242 | 154 | 10 | int:PSMB5 | |
| Interaction | MSANTD2 interactions | 1.77e-05 | 21 | 154 | 4 | int:MSANTD2 | |
| Interaction | EYA4 interactions | FOXJ2 SFPQ C15orf39 R3HDM2 SSBP3 SF1 NUP155 ZNF608 HELZ R3HDM1 | 1.82e-05 | 243 | 154 | 10 | int:EYA4 |
| Interaction | OBSL1 interactions | ZC3H14 FLNB FLNC RANBP2 SFPQ ADRM1 YBX1 CECR2 U2AF2 MCM2 ACTN4 ACTN1 AR SF1 ITPR3 PARP1 PBRM1 NUP155 CLTC KDM1A | 1.84e-05 | 902 | 154 | 20 | int:OBSL1 |
| Interaction | CHD7 interactions | 2.04e-05 | 150 | 154 | 8 | int:CHD7 | |
| Interaction | G3BP1 interactions | SOX5 CYLD ZC3H14 FLNB KLF8 RANBP2 YBX1 MCM2 AR NUP155 SMG7 EGR1 TOLLIP PPME1 ANKRD17 UNK HELZ R3HDM1 PUM1 | 2.13e-05 | 835 | 154 | 19 | int:G3BP1 |
| Interaction | MYOZ2 interactions | 2.15e-05 | 22 | 154 | 4 | int:MYOZ2 | |
| Interaction | CUX1 interactions | 2.30e-05 | 199 | 154 | 9 | int:CUX1 | |
| Interaction | MYBPC2 interactions | 2.33e-05 | 45 | 154 | 5 | int:MYBPC2 | |
| Interaction | SECISBP2 interactions | 2.95e-05 | 78 | 154 | 6 | int:SECISBP2 | |
| Interaction | CNOT3 interactions | 3.13e-05 | 207 | 154 | 9 | int:CNOT3 | |
| Interaction | SMG7 interactions | U2AF2 R3HDM2 SMG7 ZNF608 ANKRD17 UNK HELZ R3HDM1 PUM1 RBM47 KDM1A | 3.54e-05 | 319 | 154 | 11 | int:SMG7 |
| Interaction | GLDC interactions | ZC3H14 FLNB SFPQ ACTN4 ACTN1 ADD1 CEP170 PARP1 CLTC R3HDM1 PUM1 | 3.75e-05 | 321 | 154 | 11 | int:GLDC |
| Interaction | SOX7 interactions | 3.92e-05 | 82 | 154 | 6 | int:SOX7 | |
| Interaction | WDR76 interactions | FLNB RANBP2 FRAS1 SFPQ SLC31A1 YBX1 PARP2 PICALM PARP1 PBRM1 SMARCE1 KDM1A | 3.97e-05 | 383 | 154 | 12 | int:WDR76 |
| Interaction | GGA1 interactions | 4.05e-05 | 121 | 154 | 7 | int:GGA1 | |
| Interaction | MKRN2 interactions | ZC3H14 R3HDM2 CASZ1 MAGI2 PARP1 SMG7 NUMB HELZ R3HDM1 PUM1 RBM47 KDM1A | 4.17e-05 | 385 | 154 | 12 | int:MKRN2 |
| Interaction | NR2C1 interactions | 4.49e-05 | 84 | 154 | 6 | int:NR2C1 | |
| Interaction | SMG5 interactions | 4.49e-05 | 84 | 154 | 6 | int:SMG5 | |
| Interaction | PRRC2A interactions | SOX5 CYLD KLF8 SFPQ R3HDM2 SMG7 ANKRD17 UNK HELZ R3HDM1 PUM1 RBM47 | 4.61e-05 | 389 | 154 | 12 | int:PRRC2A |
| Interaction | TRIM33 interactions | CYLD KLF8 RANBP2 MCM2 ACTN4 ACTN1 SSBP3 AR NLGN3 PARP1 CLTC SSBP4 FOXF2 | 4.66e-05 | 453 | 154 | 13 | int:TRIM33 |
| Interaction | DTX2 interactions | BCL9L SFPQ C15orf39 MCM2 SF1 PARP1 NUP155 FAM168A NUMB R3HDM1 RBM47 | 4.82e-05 | 330 | 154 | 11 | int:DTX2 |
| Interaction | ADORA2A interactions | 5.02e-05 | 27 | 154 | 4 | int:ADORA2A | |
| Interaction | PXN interactions | 5.37e-05 | 334 | 154 | 11 | int:PXN | |
| Interaction | MEF2D interactions | 5.48e-05 | 87 | 154 | 6 | int:MEF2D | |
| Interaction | SIRT7 interactions | ZC3H14 FLNB FLNC RANBP2 SFPQ U2AF2 ACTN4 ACTN1 ITPR3 CEP170 PBRM1 NUP155 CLTC ANKRD17 HELZ PUM1 KDM1A | 5.65e-05 | 744 | 154 | 17 | int:SIRT7 |
| Interaction | GSK3A interactions | CYLD ZC3H14 SYNRG YBX1 U2AF2 ACTN4 BCAR1 PICALM AR ADD1 PARP1 SMG7 UNK | 5.94e-05 | 464 | 154 | 13 | int:GSK3A |
| Interaction | R3HDM2 interactions | 6.09e-05 | 129 | 154 | 7 | int:R3HDM2 | |
| Interaction | ZNF217 interactions | 6.63e-05 | 90 | 154 | 6 | int:ZNF217 | |
| Interaction | HSF1 interactions | BCL9L ZC3H14 RANBP2 SFPQ ADRM1 YBX1 MCM2 ACTN4 AKR1C1 AKR1C2 PARP1 CLTC HELZ PUM1 KDM1A | 6.89e-05 | 609 | 154 | 15 | int:HSF1 |
| Interaction | ZNF608 interactions | 7.96e-05 | 93 | 154 | 6 | int:ZNF608 | |
| Interaction | TLX3 interactions | BCL9L AOC1 C15orf39 SSBP3 AR SYNGAP1 PBRM1 ZNF608 SMARCE1 HOMEZ | 8.33e-05 | 291 | 154 | 10 | int:TLX3 |
| Interaction | AGO1 interactions | 8.38e-05 | 183 | 154 | 8 | int:AGO1 | |
| Interaction | LIN54 interactions | 8.45e-05 | 94 | 154 | 6 | int:LIN54 | |
| Interaction | PRMT1 interactions | CYLD FLNB FLNC KLF8 FAM120B SFPQ ADRM1 YBX1 PDHB U2AF2 MCM2 AR CEP170 PARP1 ASXL3 CLTC UNC93B1 PUM1 KDM1A | 8.93e-05 | 929 | 154 | 19 | int:PRMT1 |
| Interaction | DNTTIP1 interactions | 8.96e-05 | 95 | 154 | 6 | int:DNTTIP1 | |
| Interaction | PABPC1 interactions | CYLD FLNB FLNC ADRM1 YBX1 U2AF2 MCM2 R3HDM2 ACTN4 AR SMG7 UNK HELZ R3HDM1 PUM1 RBM47 | 9.26e-05 | 699 | 154 | 16 | int:PABPC1 |
| Interaction | SIRT6 interactions | FLNB RANBP2 PARP2 HECTD4 MCM2 ACTN1 ITPR3 CEP170 PARP1 PBRM1 NUP155 SAMD11 CLTC ANKRD17 KDM1A | 9.70e-05 | 628 | 154 | 15 | int:SIRT6 |
| Interaction | IGF2BP2 interactions | CYLD CNTRL RIPK2 MCM2 R3HDM2 SMG7 UNK HELZ R3HDM1 PUM1 RBM47 | 9.73e-05 | 357 | 154 | 11 | int:IGF2BP2 |
| Interaction | UBAP2L interactions | 1.01e-04 | 298 | 154 | 10 | int:UBAP2L | |
| Interaction | CNOT7 interactions | 1.02e-04 | 140 | 154 | 7 | int:CNOT7 | |
| Interaction | GAK interactions | 1.05e-04 | 189 | 154 | 8 | int:GAK | |
| Interaction | NCOA2 interactions | 1.07e-04 | 141 | 154 | 7 | int:NCOA2 | |
| Interaction | EIF4ENIF1 interactions | C15orf39 R3HDM2 SMG7 ANKRD17 UNK HELZ R3HDM1 PUM1 RBM47 KDM1A | 1.07e-04 | 300 | 154 | 10 | int:EIF4ENIF1 |
| Interaction | NFIB interactions | 1.11e-04 | 142 | 154 | 7 | int:NFIB | |
| Interaction | FAM168A interactions | 1.11e-04 | 142 | 154 | 7 | int:FAM168A | |
| Interaction | TRPS1 interactions | 1.16e-04 | 143 | 154 | 7 | int:TRPS1 | |
| Interaction | FBXL22 interactions | 1.18e-04 | 13 | 154 | 3 | int:FBXL22 | |
| Interaction | SP7 interactions | SOX5 BCL9L HHEX C15orf39 SSBP3 PBRM1 ZNF608 SMARCE1 KDM1A HOMEZ | 1.19e-04 | 304 | 154 | 10 | int:SP7 |
| Interaction | ZNF148 interactions | 1.22e-04 | 144 | 154 | 7 | int:ZNF148 | |
| Interaction | COL17A1 interactions | 1.27e-04 | 34 | 154 | 4 | int:COL17A1 | |
| Interaction | ZNF609 interactions | 1.33e-04 | 146 | 154 | 7 | int:ZNF609 | |
| Interaction | FAAP100 interactions | 1.33e-04 | 102 | 154 | 6 | int:FAAP100 | |
| Interaction | VIM interactions | CYLD WHRN AMPD2 SFPQ ADRM1 CNTRL RIPK2 MCM2 ACTN1 XKR6 SYNGAP1 BLK NFATC2 CLTC NUMB ALK KDM1A | 1.45e-04 | 804 | 154 | 17 | int:VIM |
| Interaction | RNF214 interactions | 1.48e-04 | 104 | 154 | 6 | int:RNF214 | |
| Interaction | CAPZB interactions | CYLD FLNB FLNC YBX1 PDHB WASHC1 C15orf39 U2AF2 ARHGEF18 MCM2 ACTN4 PICALM AR SF1 ITPR3 CEP170 PARP1 CLTC ANKRD17 PUM1 | 1.49e-04 | 1049 | 154 | 20 | int:CAPZB |
| Interaction | RO60 interactions | 1.55e-04 | 200 | 154 | 8 | int:RO60 | |
| Cytoband | 7q35 | 4.02e-05 | 55 | 158 | 4 | 7q35 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q35 | 8.24e-05 | 66 | 158 | 4 | chr7q35 | |
| Cytoband | 10p15-p14 | 1.75e-04 | 6 | 158 | 2 | 10p15-p14 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q13 | 1.05e-03 | 454 | 158 | 7 | chr11q13 | |
| Cytoband | 2q21.3 | 1.20e-03 | 15 | 158 | 2 | 2q21.3 | |
| Cytoband | 4q13 | 1.20e-03 | 15 | 158 | 2 | 4q13 | |
| GeneFamily | CTAGE family | 1.41e-08 | 15 | 101 | 5 | 907 | |
| GeneFamily | Actinins | 6.74e-07 | 4 | 101 | 3 | 1112 | |
| GeneFamily | Zinc fingers CCCH-type | 9.73e-04 | 35 | 101 | 3 | 73 | |
| GeneFamily | Pleckstrin homology domain containing|SH2 domain containing|C2 and RasGAP domain containing | 1.35e-03 | 10 | 101 | 2 | 830 | |
| GeneFamily | Forkhead boxes | 1.78e-03 | 43 | 101 | 3 | 508 | |
| GeneFamily | Aldo-keto reductases | 3.09e-03 | 15 | 101 | 2 | 399 | |
| GeneFamily | Wiskott-Aldrich Syndrome protein family | 3.52e-03 | 16 | 101 | 2 | 14 | |
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 3.98e-03 | 17 | 101 | 2 | 684 | |
| Coexpression | GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_CD4_TCELL_UP | 5.97e-06 | 163 | 155 | 8 | M6763 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.11e-06 | 175 | 158 | 7 | ff0789f5913c9f3c49159e40b1ec3d2ff175ec9f | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.11e-06 | 175 | 158 | 7 | 21f8f11a8b874d4f7c47931010a2535f2a5a3373 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Treg_cell_2|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.48e-06 | 178 | 158 | 7 | 829ea00c022a78d1861aa3ec53503272976775d9 | |
| ToppCell | facs-Heart-LV-18m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.02e-06 | 182 | 158 | 7 | 6dff753d65ba45db81f3cc0c9f59e1779d490955 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.17e-06 | 183 | 158 | 7 | 61a73de857f4ae02dcba3af348f436f602b28ff2 | |
| ToppCell | LAM-Lymphoid-pDC|Lymphoid / Condition, Lineage and Cell class | 4.81e-06 | 187 | 158 | 7 | 4d9ffd2bbdf1c9869e28991ce9331e4ccf3c0166 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.98e-06 | 188 | 158 | 7 | 879de94924de978478696fc7838e05a4d795b905 | |
| ToppCell | CF-Lymphoid-B_cell|CF / Disease state, Lineage and Cell class | 5.34e-06 | 190 | 158 | 7 | 374d8fd63c733178acab07682ed1519693efab45 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.92e-06 | 193 | 158 | 7 | 9c16032bc03df8760ae199e8f19fdafa4c3f1827 | |
| ToppCell | CF-Lymphoid|CF / Disease state, Lineage and Cell class | 5.92e-06 | 193 | 158 | 7 | 11de07d13a7da223990b56fa89ba7fc1c3dd0122 | |
| ToppCell | RA|World / Chamber and Cluster_Paper | 6.12e-06 | 194 | 158 | 7 | 08f0afbb68a63150fbe107a5337299081c3f69e4 | |
| ToppCell | 10x5'|World / Manually curated celltypes from each tissue | 6.33e-06 | 195 | 158 | 7 | de28b998793271c4f69ce9e183c3e62d809e9cc8 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-dn_T|COVID-19_Mild / Disease, condition lineage and cell class | 7.23e-06 | 199 | 158 | 7 | f307d4887b28cf60a591439e278fd668409cb104 | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_STALK|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 7.42e-06 | 131 | 158 | 6 | 308ddb7fe113eac5dbeb9cb0b688d9e09275ce5e | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_STALK|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.93e-05 | 155 | 158 | 6 | fe6c4aba0e98cda84bf178aeac2e9fa834477f22 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_1_(HAND1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.15e-05 | 169 | 158 | 6 | 3f738fc56bbc70dc77c9ba41025631f8264cd2b3 | |
| ToppCell | RA-01._Fibroblast_I|RA / Chamber and Cluster_Paper | 3.15e-05 | 169 | 158 | 6 | 6373562ab3b1765060212a6a53d6543e7e942e80 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.25e-05 | 170 | 158 | 6 | 928e42c51a7079c506f21c669c4e4c1a0df84d77 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.36e-05 | 171 | 158 | 6 | c3e3ea09c73050372314a89b282e36ba5f339d73 | |
| ToppCell | facs-Heart-RA-3m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.59e-05 | 173 | 158 | 6 | 49030c2dd04b592655df1a667e2f90efb499e0a5 | |
| ToppCell | facs-Heart-RA-3m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.59e-05 | 173 | 158 | 6 | 1cfbab6603f8baf8e238837bb72740c43a7dc0ec | |
| ToppCell | droplet-Fat-SCAT-30m-Lymphocytic-T_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.08e-05 | 177 | 158 | 6 | baf78a8dad55f124f56585f88b10b58c0269680f | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.34e-05 | 179 | 158 | 6 | a1ea8daa0fe8900f5a04b555c77fe8ebdaa3908d | |
| ToppCell | RA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 4.62e-05 | 181 | 158 | 6 | 2b6ddeb53a79a658e2ba78527ff48c155b20daa6 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Treg_cell_2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.62e-05 | 181 | 158 | 6 | 9275531e896e118cee043ed94fd31a0070d9581c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.62e-05 | 181 | 158 | 6 | 22363c5835dd6cef8f895ab9362e0837d92b15b1 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.76e-05 | 182 | 158 | 6 | 4a85429d365c4b2d73fc921f261b4b7635ac40bd | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.76e-05 | 182 | 158 | 6 | 53213af34af3337f5edc734d3b7b79e4349eac0d | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.76e-05 | 182 | 158 | 6 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular-Interstitial_macrophage_perivascular_L.1.2.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.76e-05 | 182 | 158 | 6 | 7909089ed6325c44edd6f9b7e8b1d542398222ea | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.21e-05 | 185 | 158 | 6 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 5.37e-05 | 186 | 158 | 6 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 5.37e-05 | 186 | 158 | 6 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | P03-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.53e-05 | 187 | 158 | 6 | 66ebe1788d51b3e17bec6cdb219f709756b4e530 | |
| ToppCell | droplet-Spleen-nan-3m-Lymphocytic-B_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.70e-05 | 188 | 158 | 6 | 8b1485e63cd4020ba5334a8d4b84725b164549bf | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.87e-05 | 189 | 158 | 6 | 5d9da836ce4308b8458bb3be3871a0aca734b6cd | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.87e-05 | 189 | 158 | 6 | 6dd4ec5ce4beb856f0d2d1654e3c4676d1d63736 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.87e-05 | 189 | 158 | 6 | ab7ece0a517499b70b7754720d3e434765363af6 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_3|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 5.87e-05 | 189 | 158 | 6 | 99b01893da9f9f7c9528afaffad178285211738b | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.87e-05 | 189 | 158 | 6 | 3ae479ec7e00c57127cbe51a398329b10ca9848c | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.87e-05 | 189 | 158 | 6 | 875df61ee48baa5142ba4d2427bdec1c53e5a828 | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.87e-05 | 189 | 158 | 6 | 97ef5215d841ff366a3e3682cd9bd04100cbfde0 | |
| ToppCell | severe-B_naive|World / disease stage, cell group and cell class | 6.04e-05 | 190 | 158 | 6 | 8dfe067d75573289299a5fba42b6c9b26e5fb430 | |
| ToppCell | 3'_v3-bone_marrow-Myeloid_Dendritic-pDC|bone_marrow / Manually curated celltypes from each tissue | 6.04e-05 | 190 | 158 | 6 | dde0e34f6a06cdbbb65c86472360c09f0279a572 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.04e-05 | 190 | 158 | 6 | 4836ea19308d2a96694f12ab0653b7ce7b101d2f | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 6.40e-05 | 192 | 158 | 6 | 6c106b91e46eabbe686a52a65a9c94ad9cbe9390 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.59e-05 | 193 | 158 | 6 | 06b65110db974f4ef90d3511ff34428976a52c9c | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 6.59e-05 | 193 | 158 | 6 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.59e-05 | 193 | 158 | 6 | a4f91bca5eaa985982d33a528f7566ffde154d47 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.59e-05 | 193 | 158 | 6 | b39d7feaac4ff8f7409cd3d15e8f3c6391367275 | |
| ToppCell | facs-Brain_Myeloid-Cortex-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-05 | 194 | 158 | 6 | 2224c7c943cfd5c1a329dfcf19d6e5ef8c49d85d | |
| ToppCell | facs-Brain_Myeloid-Cortex-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-05 | 194 | 158 | 6 | 50c5fc349533281a426bc7227a8ea9eca8d11985 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.78e-05 | 194 | 158 | 6 | 663e7e7fe48157e808b4f1a0ea6ad41944e857a2 | |
| ToppCell | facs-Brain_Myeloid-Cortex-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-05 | 194 | 158 | 6 | 1662b110f84584e75150df0ac970e7df82f26e7e | |
| ToppCell | facs-Brain_Myeloid-Cortex-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-05 | 194 | 158 | 6 | b31d6361fa939a92a4a3dc63c209ecd3eb514e6a | |
| ToppCell | RA-02._Fibroblast_II|RA / Chamber and Cluster_Paper | 6.98e-05 | 195 | 158 | 6 | 6a02ebbeb3199447ddce64d92d8809436e040eba | |
| ToppCell | (00)_Basal-(0)_Reference|(00)_Basal / shred by cell type by condition | 7.18e-05 | 196 | 158 | 6 | ba03530a20d7b29902721fd50df8d860557ddefa | |
| ToppCell | mild-dn_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.38e-05 | 197 | 158 | 6 | 07a1f59c83b748825e0708cd1cc7b63a2cb856cc | |
| ToppCell | severe-HLA-DR+_CD83+_Monocyte|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.59e-05 | 198 | 158 | 6 | a77f3440d7fb6a50066abc7e9ad59e83798ef13d | |
| ToppCell | Caecum-(5)_Dendritic_cell-(51)_cDC1|Caecum / shred on region, Cell_type, and subtype | 7.80e-05 | 199 | 158 | 6 | 2b97fda45241b2ce7be904cf081cabcf3eb5ba1d | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Vein|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.80e-05 | 199 | 158 | 6 | cfb624c7728046fc7f3ef071f57e4d7b013f3fef | |
| ToppCell | Caecum-Dendritic_cell-cDC1|Caecum / Region, Cell class and subclass | 7.80e-05 | 199 | 158 | 6 | 9ab38a0060a883de6fe3da8cdac42e124d7981d9 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.02e-05 | 200 | 158 | 6 | 2d07237022b409c4fac6fcf99b68c8affb3007cd | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_1|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.04e-04 | 131 | 158 | 5 | d46bb28612b9690b2e3550b8adbd10781788c00d | |
| Disease | focal segmental glomerulosclerosis 1 (implicated_via_orthology) | 1.25e-06 | 5 | 149 | 3 | DOID:0111128 (implicated_via_orthology) | |
| Disease | Inflammatory Myofibroblastic Tumor | 2.50e-06 | 6 | 149 | 3 | C0334121 | |
| Disease | Intellectual Disability | ZC3H14 KLF8 HIVEP2 SLC31A1 MEF2C MEIS2 SYNGAP1 PACS1 PARP1 BBS7 PUM1 TET3 | 3.08e-06 | 447 | 149 | 12 | C3714756 |
| Disease | Autism Spectrum Disorders | 4.72e-06 | 85 | 149 | 6 | C1510586 | |
| Disease | Granuloma, Plasma Cell | 2.53e-05 | 2 | 149 | 2 | C0018199 | |
| Disease | myofibrillar myopathy 5 (implicated_via_orthology) | 7.57e-05 | 3 | 149 | 2 | DOID:0080096 (implicated_via_orthology) | |
| Disease | Neoplasms, Hormone-Dependent | 7.57e-05 | 3 | 149 | 2 | C0027661 | |
| Disease | distal muscular dystrophy 4 (implicated_via_orthology) | 7.57e-05 | 3 | 149 | 2 | DOID:0111190 (implicated_via_orthology) | |
| Disease | cholic acid glucuronide measurement | 7.57e-05 | 3 | 149 | 2 | EFO_0800574 | |
| Disease | noggin measurement | 9.74e-05 | 18 | 149 | 3 | EFO_0021995 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.27e-04 | 152 | 149 | 6 | DOID:0060041 (implicated_via_orthology) | |
| Disease | X-25937 measurement | 1.51e-04 | 4 | 149 | 2 | EFO_0800937 | |
| Disease | white matter microstructure measurement, cingulate cortex measurement | 1.51e-04 | 4 | 149 | 2 | EFO_0005674, EFO_0007738 | |
| Disease | cancer aggressiveness measurement, Gleason score measurement, prostate carcinoma | 2.51e-04 | 5 | 149 | 2 | EFO_0001663, EFO_0006999, EFO_0007000 | |
| Disease | Hermaphroditism | 2.51e-04 | 5 | 149 | 2 | C0019269 | |
| Disease | Ambiguous Genitalia | 2.51e-04 | 5 | 149 | 2 | C0266362 | |
| Disease | Thymoma | 2.51e-04 | 5 | 149 | 2 | C0040100 | |
| Disease | Pseudohermaphroditism | 2.51e-04 | 5 | 149 | 2 | C0033804 | |
| Disease | Intersex Conditions | 2.51e-04 | 5 | 149 | 2 | C2930618 | |
| Disease | Sex Differentiation Disorders | 2.51e-04 | 5 | 149 | 2 | C2930619 | |
| Disease | epiandrosterone sulfate measurement | 2.67e-04 | 25 | 149 | 3 | EFO_0021120 | |
| Disease | cortolone glucuronide (1) measurement | 3.75e-04 | 6 | 149 | 2 | EFO_0800552 | |
| Disease | Antihypertensive use measurement | 4.13e-04 | 265 | 149 | 7 | EFO_0009927 | |
| Disease | docosahexaenoic acid measurement | 4.76e-04 | 127 | 149 | 5 | EFO_0007761 | |
| Disease | Disorders of Sex Development | 5.23e-04 | 7 | 149 | 2 | C0036875 | |
| Disease | X-24574 measurement | 5.23e-04 | 7 | 149 | 2 | EFO_0800897 | |
| Disease | MiT family translocation renal cell carcinoma | 5.23e-04 | 7 | 149 | 2 | C4518356 | |
| Disease | Thymic Carcinoma | 5.23e-04 | 7 | 149 | 2 | C0205969 | |
| Disease | androsterone sulfate measurement | 6.16e-04 | 33 | 149 | 3 | EFO_0021117 | |
| Disease | deoxycholic acid glucuronide measurement | 6.95e-04 | 8 | 149 | 2 | EFO_0800575 | |
| Disease | Profound Mental Retardation | 7.17e-04 | 139 | 149 | 5 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 7.17e-04 | 139 | 149 | 5 | C0025363 | |
| Disease | Mental deficiency | 7.17e-04 | 139 | 149 | 5 | C0917816 | |
| Disease | Epilepsy, Cryptogenic | 8.05e-04 | 82 | 149 | 4 | C0086237 | |
| Disease | Awakening Epilepsy | 8.05e-04 | 82 | 149 | 4 | C0751111 | |
| Disease | Aura | 8.05e-04 | 82 | 149 | 4 | C0236018 | |
| Disease | Prostatic Cancer, Castration-Resistant | 8.91e-04 | 9 | 149 | 2 | C3658266 | |
| Disease | Prostatic Neoplasms, Castration-Resistant | 8.91e-04 | 9 | 149 | 2 | C3658267 | |
| Disease | Abnormality of the face | 8.91e-04 | 9 | 149 | 2 | C4025871 | |
| Disease | systemic scleroderma, rheumatoid arthritis, myositis, systemic lupus erythematosus | 9.35e-04 | 38 | 149 | 3 | EFO_0000685, EFO_0000717, EFO_0000783, MONDO_0007915 | |
| Disease | hypertension | 9.82e-04 | 307 | 149 | 7 | EFO_0000537 | |
| Disease | Neoplasm Recurrence, Local | 1.01e-03 | 39 | 149 | 3 | C0027643 | |
| Disease | 4-androsten-3alpha,17alpha-diol monosulfate (3) measurement | 1.11e-03 | 10 | 149 | 2 | EFO_0022090 | |
| Disease | lifestyle measurement | 1.28e-03 | 235 | 149 | 6 | EFO_0010724 | |
| Disease | DNA repair protein RAD51 homolog 4 measurement | 1.35e-03 | 11 | 149 | 2 | EFO_0801531 | |
| Disease | multisite chronic pain | 1.39e-03 | 95 | 149 | 4 | EFO_0010100 | |
| Disease | bronchopulmonary dysplasia | 1.53e-03 | 45 | 149 | 3 | MONDO_0019091 | |
| Disease | cleft palate (is_implicated_in) | 1.62e-03 | 12 | 149 | 2 | DOID:674 (is_implicated_in) | |
| Disease | brain disease (is_implicated_in) | 1.62e-03 | 12 | 149 | 2 | DOID:936 (is_implicated_in) | |
| Disease | 5alpha-androstan-3beta,17beta-diol monosulfate (2) measurement | 1.62e-03 | 12 | 149 | 2 | EFO_0800291 | |
| Disease | breast cancer (biomarker_via_orthology) | 1.90e-03 | 13 | 149 | 2 | DOID:1612 (biomarker_via_orthology) | |
| Disease | androstenediol (3alpha, 17alpha) monosulfate (3) measurement | 1.90e-03 | 13 | 149 | 2 | EFO_0800293 | |
| Disease | X-19141 measurement | 1.90e-03 | 13 | 149 | 2 | EFO_0800799 | |
| Disease | Autistic Disorder | 2.17e-03 | 261 | 149 | 6 | C0004352 | |
| Disease | T wave morphology measurement | 2.21e-03 | 14 | 149 | 2 | EFO_0008398 | |
| Disease | 5alpha-androstan-3alpha,17alpha-diol monosulfate measurement | 2.21e-03 | 14 | 149 | 2 | EFO_0800283 | |
| Disease | Epilepsy | 2.30e-03 | 109 | 149 | 4 | C0014544 | |
| Disease | sleep duration | 2.50e-03 | 362 | 149 | 7 | EFO_0005271 | |
| Disease | BMI-adjusted adiponectin measurement | 2.55e-03 | 15 | 149 | 2 | EFO_0007737 | |
| Disease | Alopecia, Male Pattern | 2.55e-03 | 15 | 149 | 2 | C4083212 | |
| Disease | myelodysplastic syndrome (implicated_via_orthology) | 2.55e-03 | 15 | 149 | 2 | DOID:0050908 (implicated_via_orthology) | |
| Disease | Androgenetic Alopecia | 2.55e-03 | 15 | 149 | 2 | C0162311 | |
| Disease | Female pattern alopecia (disorder) | 2.55e-03 | 15 | 149 | 2 | C0263477 | |
| Disease | von Willebrand factor measurement | 2.88e-03 | 56 | 149 | 3 | EFO_0004629 | |
| Disease | T-Cell Lymphoma | 2.90e-03 | 16 | 149 | 2 | C0079772 | |
| Disease | response to methotrexate | 2.90e-03 | 16 | 149 | 2 | GO_0031427 | |
| Disease | Bipolar Disorder | 3.02e-03 | 477 | 149 | 8 | C0005586 | |
| Disease | lymphocyte count | SYNRG FLNB FRAS1 AOC1 ADRM1 HECTD4 C19orf47 ARHGEF18 CASZ1 HOXA3 GPALPP1 PBRM1 NFATC2 DNAH17 HELZ SMARCE1 | 3.05e-03 | 1464 | 149 | 16 | EFO_0004587 |
| Disease | Colorectal Carcinoma | FLNC SLC66A2 CSMD3 PARP1 FOXL2 NLGN4X SH3TC1 PTPRS SDCBP2 CDH7 | 3.09e-03 | 702 | 149 | 10 | C0009402 |
| Disease | brain infarction | 3.67e-03 | 18 | 149 | 2 | EFO_0004277 | |
| Disease | 5alpha-androstan-3alpha,17beta-diol monosulfate (1) measurement | 3.67e-03 | 18 | 149 | 2 | EFO_0800288 | |
| Disease | Pseudopelade | 4.09e-03 | 19 | 149 | 2 | C0086873 | |
| Disease | Alopecia | 4.09e-03 | 19 | 149 | 2 | C0002170 | |
| Disease | etiocholanolone glucuronide measurement | 4.09e-03 | 19 | 149 | 2 | EFO_0800362 | |
| Disease | intrahepatic cholangiocarcinoma (is_marker_for) | 4.09e-03 | 19 | 149 | 2 | DOID:4928 (is_marker_for) | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 4.10e-03 | 128 | 149 | 4 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 4.10e-03 | 128 | 149 | 4 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 4.10e-03 | 128 | 149 | 4 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 4.10e-03 | 128 | 149 | 4 | C1306837 | |
| Disease | Renal Cell Carcinoma | 4.10e-03 | 128 | 149 | 4 | C0007134 | |
| Disease | Prostatic Neoplasms | 4.19e-03 | 616 | 149 | 9 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 4.19e-03 | 616 | 149 | 9 | C0376358 | |
| Disease | androsterone glucuronide measurement | 4.53e-03 | 20 | 149 | 2 | EFO_0800317 | |
| Disease | schizophrenia (implicated_via_orthology) | 4.98e-03 | 68 | 149 | 3 | DOID:5419 (implicated_via_orthology) | |
| Disease | Nystagmus | 4.99e-03 | 21 | 149 | 2 | HP_0000639 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DISAMPRGTPLYGQP | 166 | Q5SW79 | |
| QGSDVMYAVEVPGPP | 176 | Q8IWZ6 | |
| SMLPSGVGPEYAERP | 1181 | Q6ZSZ5 | |
| YPGPSSTMGTVPVND | 86 | O14627 | |
| MYTVLPDGSPVPQGM | 1246 | Q7Z7A1 | |
| PDGSPVPQGMALYAP | 1251 | Q7Z7A1 | |
| IARMAPYTGPDSVPG | 861 | P12814 | |
| MPAYSGPGSVPGALD | 866 | P35609 | |
| TAPMGTVLSPDYPEG | 726 | Q7Z407 | |
| MEEPGATPQPYLGLV | 1 | Q8IX94 | |
| MEEPGATPQPYLGLV | 1 | Q86UF2 | |
| MEEPGATPQPYLGLV | 1 | P0CG41 | |
| MEEPGATPQPYLGLV | 1 | A4FU28 | |
| MEEPGATPQPYLGLV | 1 | A4D2H0 | |
| GIPPGPAVNYAVMFV | 56 | Q8N9M1 | |
| VPPSAGMGHDIYQVP | 181 | P56945 | |
| VYDTPPMAVKGPNGR | 266 | P56945 | |
| LPPEGVYMVQPQGCS | 116 | Q86V15 | |
| ARMAPYQGPDAVPGA | 881 | O43707 | |
| VVPAMASYPSGSGKP | 51 | Q01433 | |
| VTEFAVGPLPGPCYM | 111 | P19801 | |
| APSPSGIVNMDSPYG | 2316 | O75179 | |
| GTVSQFPPLYMPGLE | 1131 | Q9BXF3 | |
| PEPPLQIGSCSGYME | 246 | Q2TAZ0 | |
| FYQMPVAARGPIPTA | 1931 | Q9C0F0 | |
| TTGMPVYYSVIPPGQ | 766 | Q15032 | |
| GLPAAGVPVYYSMIP | 641 | Q9Y2K5 | |
| VGFLQPPGSEQYQMP | 666 | Q9Y2K5 | |
| MPQQYSGVSPSGPGV | 691 | Q9Y2K5 | |
| PAANVTPTKGPVYGM | 891 | P49792 | |
| PGTVAIPAIGAQYSM | 441 | A0AV96 | |
| IPAIGAQYSMFPAAP | 446 | A0AV96 | |
| QPGQEPPVTMIFMGY | 291 | O75781 | |
| VPPETYQQGLMHPGT | 876 | Q9H0J4 | |
| PPEAPVTGYMFGKGI | 881 | P09874 | |
| QGPPAMLQAYEDPGG | 896 | Q14573 | |
| GNVVEAMYGDLPPPI | 136 | Q9Y570 | |
| APPEAPITGYMFGKG | 446 | Q9UGN5 | |
| AAEPAMPNTYGVEPL | 701 | P49736 | |
| PVYQMAAGLPLSPRG | 831 | Q5VWQ8 | |
| APNSIMRPFYQGPVG | 246 | Q9NPA2 | |
| PAGYPPVAGSAVIMD | 291 | Q13469 | |
| PAVRVTGADVPMPYA | 321 | P11177 | |
| TEFNAAYVPPGLMPG | 11 | A6NJV1 | |
| MVGTPAPGGSPYGQQ | 1546 | Q86U86 | |
| GLVGYVPSVPGMVVD | 2036 | Q86XX4 | |
| AGASGEMPSQPYPAP | 261 | Q86UL8 | |
| YPAPVAAPRTNGVAM | 181 | Q92567 | |
| QGSPVFVGGSYVEPM | 361 | O43365 | |
| MQYPHPGPAAGAVGV | 1 | Q03014 | |
| QPSAPAGIGGPYMFQ | 156 | Q6UX15 | |
| GVGVPASMYGDPHAP | 16 | O14770 | |
| MGPTLAVPTPYGCIG | 1 | Q13585 | |
| PAAKGGFQVPMIPDY | 241 | P18146 | |
| GNMQVLVTYGGDPIP | 916 | O75369 | |
| RGYFGALPMVTTAPP | 26 | Q12796 | |
| STPVVMPEPNGLYGG | 4211 | Q9NYQ8 | |
| MLTEQYPQGLGPTVP | 56 | Q96AB3 | |
| HSPQQGCYPEGPMGI | 301 | Q96T54 | |
| GMEYVPPPAGSVASG | 381 | Q9H8E8 | |
| PEGHVVTYTPMAPGN | 2556 | Q14315 | |
| GPYTRVQSMALPPGV | 256 | P58012 | |
| AMVQAPPGYTLVGAD | 876 | P54098 | |
| PMVYTTLPADGGPAA | 186 | O95600 | |
| PTLPGQGMGGYPSAI | 301 | Q06413 | |
| GTTYPAMPTRPGEQA | 331 | Q9UJY5 | |
| GGMVSRVPYPSPTCV | 506 | P10275 | |
| QAGAEGYGPPPVMAM | 351 | Q9P0K8 | |
| MHPIPYPGGVQSLAG | 336 | O60431 | |
| GTYLVMLVPPPGGSG | 136 | Q9Y4D8 | |
| PAVYGGNVVMSVPLP | 1196 | P42694 | |
| YGGEAQMRFPTTLPP | 576 | O75694 | |
| GPGRTPAPVQMNLYA | 91 | Q6VY07 | |
| GFIMVYLPDGQSPVP | 1136 | Q13332 | |
| QGLAAGMPGYPVLAP | 541 | Q14671 | |
| EVPYVFGVPMVGPTD | 526 | Q9NZ94 | |
| DEVPYVFGIPMIGPT | 491 | Q8NFZ3 | |
| GAMYTLPRQATPGVP | 831 | O60341 | |
| PTVGIFITMNPGYAG | 1941 | Q9UFH2 | |
| YGRVPYPGMSNPEVI | 431 | P51451 | |
| IIGPMPAKGPVNYNV | 146 | Q8IXQ4 | |
| VGGEVYSQPPHMLSP | 1441 | Q86UU0 | |
| PMSGEYGPASVPEYE | 276 | Q9Y6X4 | |
| PPGAGVLDVMYESPF | 291 | P57775 | |
| PGRVGPTEYLSPDMQ | 341 | Q8IX15 | |
| GPYTAGVPEMSPVGT | 156 | Q9ULB5 | |
| YAGPGDTMQVELPPL | 216 | Q9NQC7 | |
| ASVDKQVGPYPGLPM | 131 | Q8IXS0 | |
| PVGQDIPYAAMGGLT | 181 | A4D161 | |
| IRYNSMPVPGPNGTI | 101 | O15431 | |
| DEVPYVFGIPMIGPT | 491 | Q8N0W4 | |
| TANGPGIYEMFGTPV | 656 | Q56UN5 | |
| GPESRQEVPMYTGPE | 466 | Q96EK7 | |
| GMPYPAPNVPVVGIT | 516 | P49757 | |
| GSTYMASCPVPAGPG | 281 | Q12947 | |
| MASNGAYPVLGPGVT | 1 | A1L443 | |
| MASNGAYPVLGPGVT | 1 | Q5VZR2 | |
| NMLDGGEYAPFVSPP | 31 | Q8N9W8 | |
| SYAVVGVPPDIMGIG | 306 | P09110 | |
| GVPPDIMGIGPAYAI | 311 | P09110 | |
| SDNIYTMINPVPPGG | 291 | Q9BWW4 | |
| KGPSPEPMYAAAVRG | 61 | Q9BWW7 | |
| ATQMPSTPGFVGYNP | 16 | Q969G3 | |
| GSPPSYEEAMQGPAA | 591 | Q8N103 | |
| GFMFPVAGGIRPPQA | 26 | Q9UMZ2 | |
| GPEAGYVATPIAMVQ | 366 | Q8NBX0 | |
| GLEMYPGTAQPAAPN | 11 | Q99527 | |
| IPPPVAFSMGSGYTF | 671 | Q92540 | |
| AGPAAGTPPCQMGVY | 66 | Q8TE82 | |
| QTPGYGFLPPAQAEM | 326 | Q96NU1 | |
| YPPGPSAMVATVCGL | 76 | Q9BR26 | |
| RQPPGPGAGDTYSMV | 506 | Q9P202 | |
| SGLGGVGDPYVPLMV | 246 | Q8TC41 | |
| GMAPGIGPISFPEAQ | 666 | Q9UQ90 | |
| AVCDGMPLGYVPPTA | 401 | A1L4H1 | |
| PGPGQMVAPVTGYSL | 81 | Q9H190 | |
| TYNPVPGVMDGVPSA | 256 | P31937 | |
| YEGQVSGMPNDPSPL | 1131 | Q9UM73 | |
| MPVLGFGTYAPAEVP | 16 | Q04828 | |
| MPVLGFGTYAPAEVP | 16 | P52895 | |
| EYLNNPPMPGALGAS | 126 | Q16186 | |
| NVPNVYPAAPQGGMA | 101 | P35611 | |
| PGFMGKATPPYDVQV | 386 | Q08AH1 | |
| PPGQAGKSVPGYNVM | 471 | Q9H6R3 | |
| PIVYGQPQLMLTAGP | 1631 | Q00610 | |
| VMYHQPTANPGLGGP | 146 | Q9H9P2 | |
| PLYSTGMAGPPLQAD | 71 | Q6ZRI6 | |
| CEGVQGPPMAPEKYT | 791 | O94762 | |
| PVMAYPATTPTGMIG | 596 | Q13492 | |
| GYEANPGVPPATMSG | 641 | P23246 | |
| VEPMAPEIPGYRGTQ | 526 | Q5GH73 | |
| GTVEIQALGMQPYPP | 231 | Q9BYN7 | |
| MPPAQGYEFAAAKGP | 1 | Q9NUR3 | |
| PLYPMAGAAGPQGDE | 6 | Q9H1C4 | |
| PQYSNPPVQGEVMEG | 206 | P67809 | |
| AVAAGNSGDPYPMGP | 1451 | Q99973 | |
| PGGKQYSMEGAPAAP | 111 | Q96PV0 | |
| RGPGSPGEPMEKYQV | 16 | Q8NE28 | |
| PYTVQAGLPLNPMGR | 1316 | O94759 | |
| EGGTIIYMPPENYEP | 186 | O43353 | |
| TPPRGMASVGPQSYG | 201 | Q9BWG4 | |
| MYIADLGPGIAPSAP | 261 | Q6VEQ5 | |
| GVGYVPITGMPAVCS | 196 | Q9H0E2 | |
| MYSADLGPGIAPSAP | 261 | A8K0Z3 | |
| MLPGGPPDYNTALDV | 191 | Q93063 | |
| SAAAIAPQMPPAGIY | 256 | A0A0J9YWL9 | |
| PVPGQMDSGPVYHGD | 131 | O43151 | |
| MQASVPGPSEEPVVY | 646 | Q8NB14 | |
| PGMSENPSVYVPGVV | 236 | P26368 | |
| PSYMHPGQVGAPAAG | 1006 | Q9ULD9 | |
| SPEPGMPVIQSTYGV | 701 | P35711 | |
| GGFLFPPSYVPVVMS | 186 | P54855 | |
| MYQTPLPGEMSPEGE | 486 | Q9ULD5 | |
| GEYFMDPVVPLQGVP | 671 | P31629 | |
| GPVLYMPSAAGDSVP | 341 | Q9C0B0 | |
| VYNGPMAGVPGPATV | 166 | A0A1B0GWB2 | |
| MGQPAPYAEGPIQGG | 1 | Q8N2I2 | |
| TLDGVPSPPGYMSDQ | 521 | Q6PJT7 | |
| AAAAMVFGGVVPYVP | 21 | Q8N2U9 | |
| PMDQYLGSTPVGSGV | 446 | Q15637 | |
| GGFLFPPSYVPVVMS | 186 | O75795 | |
| TPPSMGVTVAGAYPA | 601 | Q14003 | |
| MVSLNPGGDPSTPGY | 346 | Q58DX5 | |
| MPVPAQPKAGGSGSY | 116 | Q96NY9 | |
| YPFILPDMVGGNAVP | 546 | Q6NSJ0 |